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PREFACE 
Molecular recognition is the central element from which an entire biochemi-
cal universe is built. The function of proteins, the dominant biomolecular ma-
chines, is mediated by their interaction with partners that can vary from small 
molecules to very large molecules, such as other proteins and nucleic acids. Pro-
tein-protein and protein-nucleic acid interactions are ubiquitous and essential to 
all known cellular and physiological processes. Macromolecular recognition is 
the origin of biological specificity. It takes place in a crowded noisy biochemi-
cal environment and requires the recognition of a specific target within a back-
ground of various often similar competing molecules. In such biological envi-
ronment molecular selectivity and affinity provide the ground for any recogni-
tion phenomenon. The conformational flexibility of recognizers plays a key role 
in the optimization of the intermolecular interactions.  
One limitation that delays the understanding of molecular recognition is the 
lack of high-resolution three-dimensional structures of biomacromolecules in 
assemblies. The challenge of understanding the molecular driving forces in the 
recognition process has indeed stimulated over the last fifty years the determina-
tion of the atomic structure of a great number of protein-protein and protein-
DNA complexes. In this field a key role has been played by X-ray crystallog-
raphy. In particular, structural studies suggest that high affinity interactions arise 
from the sum of many close range non-covalent contacts that represent the driv-
ing force of molecular recognition. The crystallographic approach has provided 
more insights on biological properties of complexes between macromolecules, 
allowing a deeper knowledge of physiological processes and opening new per-
spectives to drug design. 
The central objective of this PhD project has been the structural characteri-
zation of recognition processes related to human diseases. The communication 
between the interacting molecules has been analyzed using X-ray crystallog-
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raphy as the main technique, in combination with other biophysical techniques, 
such as CD, fluorescence spectroscopy and AFM.  
This thesis is divided in two parts. In the first part, modulation of human α-
thrombin function with nucleic acid aptamers is investigated from a structural 
point of view. The molecular determinants in the recognition between thrombin 
and the best known 15-mer aptamer HD1 are deeply reviewed and discussed on 
the basis of the structure of two complexes between the protein and two deletion 
mutants of HD1. Moreover, the structure of the more powerful aptamer HD22, 
targeting a different thrombin exosite, is finally unraveled and discussed. On the 
basis of this structure, a bunch of literature data, till now been considered un-
clear and ambiguous, could be explained and rationalized.  
The second part of the thesis is focused on protein self-recognition and oli-
gomerization through 3D domain swapping. It has been shown how this mecha-
nism can lead to the formation of dimers, oligomers, and, as an extreme case, 
fibrils. The work on simple model proteins, usually non-directly associated with 
a disease, has helped the understanding of the more complex behavior of dis-
ease-associated proteins. In this context a peculiar role has been played by the 
mammalian pancreatic-type ribonuclease family, which has been used as model 
system in various studies on the protein oligomerization process. 3D domain 
swapping has been found to endow some of this proteins with special functions, 
besides their normal enzymatic activity, such as cytotoxic activity. In particular, 
the oligomerization has been used to convert the non-cytotoxic bovine pancreat-
ic ribonuclease (RNase A) in multimeric protein with medical relevance as anti-
tumor drugs. The final aim is the production of new ribonuclease oligomers 
with improved antitumor activity for the treatment of human cancer and able to 
be well-tolerated by patients. The main idea developed in this thesis has been 
the use of protein engineering to force monomeric proteins to form high stable 
domain-swapped dimers or oligomers that could be used as a new generation of 
antitumor agents.  
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Finally, a new very interesting evidence that domain swapping is involved 
in the assembly of fibrillar aggregates has been obtained. These results support 
the hypothesis that the subunits of the fibril retain much of the native structure 
of the protein.  
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PART I: THROMBIN – APTAMER 
RECOGNITION 
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STATE OF THE ART 
Nucleic Acid Aptamers 
Since their discovery in the second half of 19th century (Dahm, 2008), nucle-
ic acids have been thought exclusively as genetic information carriers, contain-
ing the encoded information for the translation to proteins (Watson, et al., 1953; 
Crick, 1970). However, in recent years, new activities for nucleic acids have 
been discovered since they have been found to be involved in a series of other 
less known processes (Bloomfield, et al., 2000). The discovery of nucleic acid 
sequences with catalytic and regulatory activities over the past decades illumi-
nated a whole new array of functions that can be conducted by these macromol-
ecules. In particular, at the beginning of the 1990s, an interesting property of ri-
bonucleic acid was disclosed. It was observed that short RNA molecules could 
fold into three-dimensional structures and specifically bind different non-nucleic 
acid targets (Ellington, et al., 1990). The conformation of nucleic acids, encoded 
in their primary sequence, is the element that drives the specific and selective 
interaction with a target. Despite their rather high flexibility, these DNA or 
RNA molecules, referred to as nucleic acid aptamers, can undergo adaptive 
binding upon target recognition, by switching from a loose conformation to a 
distinct more ordered structure (Hermann, et al., 2000; Tan, et al., 2011). 
In vitro selection 
Aptamers are single-stranded DNA or RNA sequences, generated through in 
vitro selection, which adopt stable three-dimensional structures having a good 
shape complementarity with their target. A procedure to derive sequences rec-
ognizing specific targets was first described by Tuerk and Gold under the name 
of Systematic Evolution of Ligands by EXponential Enrichment (SELEX) 
(Ellington, et al., 1990; Tuerk, et al., 1990). It is a combinatorial chemistry pro-
cedure that allows rapid selection of a DNA or RNA aptamers that have appro-
priate binding affinity to a given molecular target, starting from a large initial 
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library of oligonucleotides (108 random sequences are usually screened). Up to 
date a large number of different DNA and RNA aptamers were isolated against 
a wide range of targets (Zhu, et al., 2012; Radom, et al., 2013): from small mol-
ecules (Hermann, et al., 2000; Miyachi, et al., 2009) to proteins (Bock, et al., 
1992; Chi-hong, et al., 2003; Daniels, et al., 2003; Khati, et al., 2003; Parekh, et 
al., 2010), virus-infected cells (Tang, et al., 2009; Keefe, et al., 2010), stem 
cells (Guo, et al., 2006), and cancer cells (Chen, et al., 2008). 
Structure 
Aptamer can fold in unique and well-defined three-dimensional structures. 
Sometimes they assume intricate and unpredictable conformations, in order to 
interact closely with or adhere to the surface of their target. The multitude of 
folding motifs they can assume allows them to bind to almost any small mole-
cule, nucleic acid or protein target with high specificity and affinity. 
Several motifs of aptamers have been described, the most famous being the 
hairpin structure (Fan, et al., 1996), the pseudo-knot (Lorsch, et al., 1994) and 
the G-quadruplex (Macaya, et al., 1993). Furthermore, it is well-known and 
documented that their conformation is strictly dependent on the concentration 
and kind of ions in solution (Draper, et al., 2005; Girardot, et al., 2010).  
Among the large number of structural arrangements adopted by aptamers, 
the four-stranded topology called G-quadruplex has become of great interest, 
since it has been found to be implicated in relevant biological processes 
(Mergny, et al., 1998; Hurley, 2002; Neidle, et al., 2002; Kumari, et al., 2007; 
Patel, et al., 2007; Fernando, et al., 2009; Lipps, et al., 2009). Moreover it rep-
resents an attractive molecular scaffold to be used for drug design 
(Balasubramanian, et al., 2009).  
Quadruplex nucleic acids may be defined as higher order structures formed 
by DNA or RNA sequences containing at least one tract of contiguous guanine 
nucleotides (Neidle, 2009). The main component of the G-quadruplex is the G-
tetrad or G-quartet, a roughly planar arrangement of four guanine bases associ-
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ated through a cyclic array of Hoogsteen-like hydrogen bonds, in which each 
guanine base both accepts and donates two hydrogen bonds. This planar ar-
rangement of guanines has a high propensity to self-stack. G-quadruplexes con-
tain a core of at least two stacked G-quartets, stabilized by interaction of cations 
with the O6 atoms of guanines belonging to the cyclic array (Williamson, 1994). 
Indeed, the overall G-quadruplex arrangement is critically dependent on the na-
ture of counter ions (Engelhart, et al., 2009). Quadruplex arrangements can be 
classified on the basis of the molecularity of the quadruplex formation process. 
Thus monomolecular (intramolecular), bimolecular, and tetramolecular quadru-
plexes do exist. Within the rather rigid structure of the G-quadruplex core, a 
great topological variation is allowed. The sequences linking the G-tracts in a 
bimolecular or monomolecular G-quadruplex are called loops and the number of 
ways they can connect the guanines constituting the G-core generates several 
topological variations of the G-quadruplex itself. Some G-quadruplex topolo-
gies and loops types are described in Figure 1 and Figure 2. 
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(a) 
 
(b) 
 
Figure 1. (a) Some possible topologies for simple tetramolecular (on the left-hand side) and bimo-
lecular quadruplexes. Strand polarities are shown by arrows. (b) Some possible topologies for 
simple unimolecular quadruplexes. Image taken from (Burge, et al., 2006). 
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Figure 2. Schematic views of various intramolecular quadruplex topologies. (a) Antiparallel to-
pology as found in the Na+ form of a human telomeric quadruplex (Wang, et al., 1993). (b) Paral-
lel fold as found in the crystal structure of a K+ form of a human telomeric quadruplex (Parkinson, 
et al., 2002). (c) (3 + 1) hybrid topology (form 1) as found in the NMR structures of the K+ form 
of human telomeric quadruplex sequences (Ambrus, et al., 2006; Luu, et al., 2006). (d) (3 + 1) 
hybrid topology (form 2) as found in the NMR structures of the K+ form of human telomeric 
quadruplex sequences (Phan, et al., 2006; Dai, et al., 2007). Note that the order of loops is now 
reversed compared with that in form 1. (e) Topology of the c-kit promoter quadruplex (Phan, et 
al., 2007). Image taken from (Neidle, 2009).  
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Advantages of aptamers 
Aptamers are considered a sort of nucleic acid version of antibodies, holding 
many advantages over them: they have higher thermal stability, tolerance to 
wide ranges of pH and salt concentration, and they can be much more easily 
synthesized (Jayasena, 1999). Nucleic acid aptamers can be developed against a 
wide range of targets, including those toxic to organisms and therefore beyond 
the reach of antibody development. Moreover, aptamer identification through in 
vitro SELEX is usually more efficient and cost-effective than antibody devel-
opment. The advancement of automated nucleic acid synthesis enables easy, 
cost-effective chemical synthesis and modification of functional moieties, as 
well as large-scale commercial production. Other advantages include rapid tis-
sue penetration based on the relatively small molecular weights, low immuno-
genicity, and ease of antidote development (Rusconi, et al., 2004; Oney, et al., 
2009). These advantages makes aptamers more than attractive for clinical or bi-
omedical applications, such as disease diagnosis and therapy. 
Aptamer as anticoagulants 
In addition to specific recognition abilities, some aptamers can bind to and 
further modulate the biological activities of the molecular targets which are in-
volved in pathogenesis or in key physiological processes. As a consequence, ap-
tamers, as therapeutics, can readily regulate biological pathways and interfere 
with disease development (Nimjee, et al., 2005b). In particular, aptamer tech-
nology is extensively used to modulate the function of most of the serine prote-
ases and the cofactors involved in the coagulation pathway. 
The high affinity of the selected aptamers allows for therapeutic dosing at 
submicromolar levels, which should reduce potential non-specific effects. 
Moreover, they are non-immunogenic and show tunable and predictable phar-
macokinetic properties. In fact, aptamer in vivo half-life, which is usually very 
short and in the order of few minutes, can be prolonged (up to few hours) by 
chemical modifications (e.g. high molecular weight polyethylene glycol can be 
 19 
conjugated to the aptamer). Furthermore and most importantly, antidotes can be 
rationally designed to control their pharmacologic activity. This property is 
unique to aptamers and makes this class of molecules very interesting for anti-
coagulant drugs (Nimjee, et al., 2005a).  
Human alpha thrombin 
Thrombin activity is central to hemostasis, the balance between thrombosis 
and bleeding (Stubbs, et al., 1995), and consequently this enzyme is an im-
portant target of anticoagulant therapies. 
Human α-thrombin (thrombin) is a trypsin-like serine protease that has been 
the focus of intense study since its discovery and continues to draw attention 
and research funds in the biomedical field. This is in part due to the position of 
thrombin at the end of the blood clotting cascade, and to its unique ability to 
cleave fibrinogen to the polymerogenic fibrin. Thrombin plays a pivotal role in 
the feedback activation of coagulation factors: it participates in the cleavage of 
fibrinogen to form blood clots, but also initiates anticoagulation by activating 
protein C. The delicate equilibrium between the coagulant and anticoagulant ac-
tivation by thrombin is essential in the normal physiological state, preventing 
clot formation in undamaged vessels and triggering the coagulation cascade in 
the damaged ones. Indeed, thrombin generation is closely regulated to locally 
achieve rapid hemostasis after injury, without causing uncontrolled systemic 
thrombosis. In the absences of efficient and timely thrombin generation, stable 
blood clots cannot form, resulting in hemorrhage. On the other hand, an exces-
sive coagulation function results in dissemination of the clot in undamaged tis-
sues, causing thrombosis (Di Cera, et al., 1997; Coughlin, 1999; Huntington, 
2005; Crawley, et al., 2007; Di Cera, 2007).  
Thrombin capability to perform such different functions rely on the ability 
to recognize a large variety of substrates, inhibitors and cofactors (Bock, et al., 
2007). This ability is finely regulated by two distinct regions on the surface of 
thrombin, known as exosites I and II, which allosterically modulate its function, 
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thus providing specificity to the proteolytic activity of the protein (Di Cera, et 
al., 2007). In particular, exosite I is also known as the fibrinogen recognition 
site (FRE) since it is the binding site of thrombin physiological substrate fibrin-
ogen, whereas exosite II, which is positively charged, is the binding site of 
thrombin inhibitor heparin (Bode, 2006). Given the ability to modulate the 
recognition with a large number of molecules, thrombin is usually considered a 
suitable target for anticoagulant and antithrombotic agents. It is thus clear that 
the ability of inhibiting and regulating thrombin activity in vivo by synthetic 
compounds is an important goal in the prevention and treatment of clotting ab-
normalities.  
Thrombin inhibition can be achieved by different mechanisms (Lombardi, et 
al., 1999). An option is blocking its active site, through the binding of substrate 
analogues that form covalent bonds with thrombin catalytic residues: in this way 
the hydrolysis of both macromolecular and small substrates is prevented. An-
other mechanism is blocking the binding of macromolecular substrates at exo-
site I or even favoring the binding of thrombin to SERPINs (SERine Protease 
INhibitors), which irreversibly suppress thrombin activity. The last mechanism 
is that by which heparin acts: it binds thrombin exosite II and drives the for-
mation of the complex between thrombin and a SERPIN, antithrombin (Rau, et 
al., 2007; Nutescu, et al., 2008). 
The X-ray crystal structure of thrombin was solved for the first time in 1992 
by Bode et al. (Bode, et al., 1992) and determined in its complex with the spe-
cific thrombin inhibitor D-Phe-Pro-Arg chloromethylketone (PPACK). PPACK 
binds covalently two of the three residues composing the catalytic triad (the 
characteristic serine-histidine-aspartate catalytic triad), thus preventing throm-
bin autolysis. 
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CHAPTER I – HD1: YOU NEVER FORGET THE FIRST 
LOVE 
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INTRODUCTION 
The most extensively studied thrombin binding aptamer is a 15-mer DNA 
oligonucleotide with sequence 5’-GGTTGGTGTGGTTGG-3’, named HD1. It 
has been discovered in 1992 by in vitro selection (Bock, et al., 1992) and it is 
known to bind at exosite I (Wu, et al., 1992; Paborsky, et al., 1993; Tsiang, et 
al., 1995), inhibiting thrombin-catalyzed fibrin clot formation (Griffin, et al., 
1993; Li, et al., 1994). HD1 adopts a monomolecular antiparallel G-quadruplex 
structure with two G-tetrads, built around a centrally located monovalent cation 
(usually K+), and three edge-wise loops: a TGT loop protruding in the solvent 
from one side of the G-quadruplex and two TT loops from the opposite side 
(Macaya, et al., 1993). The π–π stacking of aromatic bases of the guanines 
plays an important role in the stability of the G-core, in which the two G-tetrads, 
assembled via the Hoogsteen-type hydrogen bond pattern, stack on top of each 
other to form a quadruple helix segment (Figure 3) (Burge, et al., 2006).  
 
Figure 3. Cartoon representation of the G-quadruplex structure of HD1 (PDB entry 4dih). The 
eight guanines involved in the two G-tetrads are colored in dark grey, and the loop residues in 
light grey. The black sphere represents the cation stabilizing the G-core.  
Several studies aimed at modulating thrombin function through modification 
of the aptamer TT loops have also been reported (Heckel, et al., 2005; 
Bonifacio, et al., 2008; Nagatoishi, et al., 2011). Up to now, only very few 
modifications have led to an improvement of the anticoagulant activity 
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(Musumeci, et al., 2012). Recently, it has been shown that mutation of TT loops 
by the replacement of a thymine residue with adenine or with a dSpacer de-
creases the thermal stability and the binding affinity of HD1 for bovine throm-
bin (Nagatoishi, et al., 2012). This result was partly ascribed to a modification 
near the deletion site of the hydration pattern that mediates the recognition be-
tween the modified aptamer and the protein (Nagatoishi, et al., 2012). 
Intramolecular G-quadruplex scaffolds can be easily modified to increase 
their stability and nuclease resistance and/or to improve the binding with a spe-
cific target molecule (Borbone, et al., 2012; Sagi, 2013). These features have 
been extensively exploited to enhance antithrombotic activity, to tailor the 
pharmacokinetic profile, to modulate renal clearance and the rate of tissue dis-
tribution (Bunka, et al., 2006). The effects of the explored modifications can be 
more easily and clearly interpreted on the basis of well-defined structural mod-
els of the enzyme-aptamer interaction site. Recently, the structural details of 
thrombin complexed with HD1 and mTBA, an analogue that contains a 5’-5’ 
polarity inversion site between T3 and T4, have been unambiguously estab-
lished at high resolution (Russo Krauss, et al., 2011; Russo Krauss, et al., 
2012). These crystallographic models have clearly highlighted the role of the 
aptamer TT loops performed in the recognition process. In particular, the two 
loops act as a pincer-like system that embraces the protruding region of throm-
bin exosite I.  
In order to better clarify the contribution of each TT loop to the binding, in 
my PhD I have focused my work on two complexes between thrombin and two 
HD1 mutants. In these mutants, the nucleobase of either thymine 3 (T3) or thy-
mine 12 (T12) is substituted with an abasic furan (dSpacer), from now on re-
ferred to as dS. Both variants, hereafter denoted as HD1ΔT3 and HD1ΔT12, 
show a decreased affinity toward the target protein with respect to the unmodi-
fied HD1 (Nagatoishi, et al., 2012).  
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RESULTS  
Overall survey of the two complexes 
Structural features of the complex between thrombin and HD1ΔT12, and 
HD1ΔT3, have been investigated by X-ray diffraction (Figure 4).  
 
Figure 4. Deletion mutants of HD1 represented as cartoon. The dSpacer is colored in black in both 
oligonucleotides.  
Well-ordered crystals, diffracting to 1.65 Å, were grown for the complex 
with HD1ΔT12. Crystals are triclinic with one complex in the unit cell. The re-
fined atomic model converged to R/Rfree values of 0.155/0.190.  
The complex with HD1ΔT3 produces less ordered crystals, whose diffrac-
tion pattern fades out at 2.55 Å. The asymmetric unit of the monoclinic P21 unit 
cell contains two molecules of the complex, related by a pseudo-two-fold sym-
metry axis parallel to a. At convergence the R/Rfree values were 0.168/0.227, 
respectively. The two structural models are shown in Figure 5. 
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Figure 5. Overall structures of thrombin–HD1∆T3 and thrombin–HD1∆T12 complexes (PDB en-
try 4lz1 and 4lz4).  
Focusing on thrombin 
The aptamer binding does not substantially modify the thrombin structure. 
No significant variations are found in the protein structure when the structural 
models of thrombin-HD1ΔT12 and thrombin-HD1ΔT3 complexes are com-
pared (RMSD of 0.90 Å, calculated on all atoms). Similar results are obtained 
when the models of thrombin-HD1ΔT12 and thrombin-HD1ΔT3 are compared 
with that of thrombin-HD1 (PDB entry 4dih) complex (RMSD of 0.70 Å and 
0.96 Å for thrombin-HD1ΔT12 and thrombin-HD1ΔT3 complexes, respective-
ly). 
Furthermore, while for the structure of thrombin-HD1ΔT12 no electron 
density is observed in the region of thrombin γ-autolysis loop (residues 147–151 
of the heavy chain), as usually found in thrombin crystal structure, this region is 
well-defined in thrombin-HD1ΔT3 complex. In the latter crystal organization, 
the loop conformation is stabilized by the interactions between the two mole-
cules in the asymmetric unit. After superposition, the root mean square devia-
tion (RMSD) between all the atoms of the two thrombin-HD1ΔT3 complexes in 
the asymmetric unit was 0.62 Å (0.37 Å when only the protein atoms were con-
sidered).  
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Analyzing the aptamer moieties 
Regarding the oligonucleotide units, only small changes in HD1ΔT12 and 
HD1ΔT3 overall fold are observed. Both the aptamers retain the expected quad-
ruplex chair-like structure stabilized by a potassium ion localized at the center 
of the two G-quartets. The cation guarantees the formation of coordination 
bonds with the O6 atoms of the eight-purine according to a distorted anti-prism 
geometry (Figure 6). Thus, it can be stated that the nucleobase deletion, either of 
T12 or T3, does not alter the overall G-quadruplex architecture, which is as-
sured by the π-stacking of the two bases T4 and T13 with the guanine tetrads. 
 
Figure 6. 2Fo–Fc electron density maps at 2.0 σ level of the G-tetrads (thrombin–HD1∆T12 com-
plex) in two different orientations with the potassium ion at the center. Carbon atoms are green, 
nitrogen blue, oxygen red, phosphorus orange and potassium purple. 
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Differences between the complexes 
The main structural differences between the two complexes arise from the 
orientation of the bound aptamer with respect to the protein (Figure 5). Indeed, 
after superposition of thrombin molecules, the two aptamers are related by a 
180° rotation around the axis normal to the quadruplex moiety and passing 
through the cation (quadruplex axis). The RMSD is of about 0.4 Å, calculated 
excluding the TGT loop. In particular, in the complex of HD1ΔT12, the T3T4 
loop interacts with residues Arg75, Glu77, Arg77A, Asn78 and Ile79 of throm-
bin, hereafter referred to as A-region, and the dS12T13 loop makes contacts 
with Arg75 and Tyr76 (B-region) (Figure 7). On the contrary, in the complex of 
HD1ΔT3, the T12T13 loop interacts with the A-region and the dS3T4 loop with 
the B-region. Therefore, in both cases, the unmodified TT loop interacts with 
the A-region while the base-deficient dST loop interacts with the B-region. 
Arg75 represents the boundary residue between the two zones; it interacts with 
both TT loops through contacts with the two stacked bases T4 and T13 (Figure 
7).  
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(a) 
 
(b) 
 
Figure 7. Thrombin–aptamer recognition site in thrombin–HD1∆T12. (A) A-region of exosite I 
interacts with the TT loop (on the left) and is colored orange, while B-region interacts with the 
modified dST loop and is colored green. Arg75, drawn in black, interacts with both loops and 
marks the transition from the A- to the B-region. (B) Electron density of the dST loop and Tyr76 
and Arg75 of the B-region contoured at 2.0 σ level. Oxygen atoms are red and nitrogen blue. Car-
bon atoms are colored according to the structural element they belong to (dark blue for the ap-
tamer loops, orange for thrombin region-A, black for Arg75 and green for region-B). 
  
 30 
The interacting surface area (thrombin/aptamer) for all the known thrombin-
TBAs complexes is reported in Table 1.  
Table 1. Interface area (Å2) between thrombin and the aptamer in several complexes reported in 
the PDB. 
  
HD1ΔT3 
(4lz4) 
HD1ΔT12 
(4lz1) 
HD1 in K+ 
(4dii)  
Space group P21 P1 P1 
Whole interface 524 529 540 
Thrombin A-region contribution 294 (T12T13) 295 (T3T4) 282 (T3T4) 
Thrombin B-region contribution 157 (dS3T4) 163 (dS12T13) 184 (T12T13) 
 
  
HD1 in Na+ 
(4dih) 
mTBA 
(3qlp) 
HD1 
(1hao) 
Space group P1 I222 P212121 
Whole interface 563 663 544 
Thrombin A-region contribution 295 (T3T4) 306 (T12T13) 281 (T12T13) 
Thrombin B-region contribution 195 (T12T13) 280 (T35’-5’T4) 183 (T3T4) 
 
The relative contribution of the A- and B-region is highlighted. The data in-
dicate that the binding of a TT loop at the A-region of the protein generally en-
gages a higher contact area compared to the B-region. The binding to the A-
region is mostly contributed by a crevice on the protein surface lined by the hy-
drophobic side chains of Ile24, Ile79 and the phenyl ring of Tyr117, where the 
sugar moiety of T3 (in HD1ΔT12) or T12 (in HD1ΔT3) is located (Figure 8). In 
the more external part of the cavity the nucleobase of the residue is tightly 
packed among the side chains of His71, Ser72, Arg75, and Glu77, where the 
base forms hydrogen bonds with OE1 of Glu77 and NH1 of Arg75 (Figure 8).  
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Figure 8. Thrombin crevice hosting the TT loop in thrombin–HD1∆T12. Residues lining the crev-
ice are colored blue. Arg75, which is external to the crevice, is colored orange. For the residues 
T3, T4 and T12, carbon atoms are green, nitrogen blue and oxygen red. 
The cavity is capped by the backbone of the aptamer, which forms an addi-
tional hydrogen bond with the hydroxyl group of Tyr117. These features make 
the crevice a highly stable and specific anchoring region for a thymine residue 
on the protein surface. The B-region is considerably less specific for the second 
TT loop of the aptamer. In particular, in the structure of the thrombin-HD1 
complex (Russo Krauss, et al., 2012), the interactions involve the side chains of 
Arg75 (see above) and Tyr76 that makes hydrogen bonds with T13 and hydro-
phobic contacts with the T12 nucleobase. No structural modification in the pro-
tein is observed as a consequence of the loss of the interaction between Tyr76 
and the missing nucleobase (T3 or T12 for HD1ΔT3 and HD1ΔT12, respective-
ly). However, the aptamer undergoes to a local conformational modification in-
volving the sugar ring of the dS residue (in both HD1ΔT3 and HD1ΔT12) that 
gets slightly closer to Tyr76 with respect to the corresponding T12 in the 
thrombin-HD1 structure. This rearrangement gives rise to hydrophobic interac-
tions between the ribose and Tyr76, which partly compensate the interaction lost 
with the nucleobase deletion. 
As far as the TGT loop is concerned, in neither complexes the electron den-
sity is well-defined. Moreover, its conformation depends on packing interac-
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tions and, thus, from the crystal space group, which is, by the way, different in 
the two cases. 
The high quality of the diffraction data measured for thrombin-HD1ΔT12 
complex has provided a detailed picture of the bound water molecules at the in-
terface between the TT loops and thrombin; the resulting hydration pattern does 
not show any major difference with that found in the high resolution structures 
of thrombin-HD1 complexes (PDB entries 4dih and 4dii). Unfortunately, the 
lower resolution of the thrombin-HD1ΔT3 diffraction data leads to less clear-
cut description of the solvent molecules, making ambiguous a detailed compari-
son of the hydration pattern at protein-aptamer recognition site. 
DISCUSSION 
G-quadruplex scaffold and thrombin exosite I 
The versatility of G-quadruplex aptamers as ligands is currently used in sev-
eral topic research areas (Davis, 2004). In order to improve their performance, it 
is critical to understand the relative contributions of the quadruplex plasticity 
and the specificity of the protein-ligand interactions in the recognition process.  
This work has dissected the contribution of each TT loop in the recognition 
process between thrombin and HD1 by a crystallographic analysis of the inter-
action between two aptamer variants lacking a thymine nucleobase and the hu-
man enzyme. The structures of thrombin-HD1ΔT12 and thrombin-HD1ΔT3 
provide new information about the specific contribution to the binding of the 
two regions in which exosite I, involved in the interaction with the TT loops, is 
split. It should be stressed that, with the only exception of the TGT loop (that 
does not interact with thrombin), HD1 possesses an almost exact two-fold axis 
coincident with the quadruplex axis. Therefore, in the unmodified HD1 two 
equivalent modes of binding, which differ only in the orientation of the TGT 
loop, are allowed. These two modes of binding have been found in two different 
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crystal structures of thrombin-HD1 complex (PDB entries 1hao and 4dih). In 
particular, the A-region of exosite I interacts with T12T13 in 1hao and with 
T3T4 in 4dih, and vice versa for the B-region (Figure 9).  
 
Figure 9. Interaction between thrombin and HD1. The two structures of thrombin–HD1 complex 
deposited in the PDB as 1hao and 4dih are shown as cartoon, after superposition of the thrombin 
molecule. The two oligonucleotides (light blue for 1hao and dark blue for 4dih) differ in the posi-
tion of their TGT loops (in orange). 
Any chemical modification of one TT loop removes the degeneracy of the 
two binding modes, as it happens for example in the case of mTBA (Russo 
Krauss, et al., 2011), a variant of HD1 in which a 5’-5’ inversion of polarity site 
has been introduced between T3 and T4 (Martino, et al., 2006). Interestingly, in 
the structures of thrombin-HD1ΔT12 and thrombin-HD1ΔT3 the aptamer binds 
at exosite I in such a way to preserve the interactions of the unmodified TT loop 
with the A-region, whereas the modified dST loop interacts with the B-region. 
Therefore, the overall interactions of the two modified aptamers with thrombin 
are practically the same, in good agreement with the values of the binding con-
stants recently reported in the literature (Nagatoishi, et al., 2012).  
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CONCLUSIONS AND FUTURE PERSPECTIVES 
Aptamers targeting exosite I 
HD1 targets thrombin acting as a pincer-like system with the two TT loops 
embracing the protruding region of exosite I. The identity of the two TT loops 
gives rise to two practically equivalent binding modes to thrombin, which differ 
only for the dissymmetry element TGT, exposed to the solvent and located far 
away from the protein. In solution the two different complexes are likely to be 
equally populated and their selection in the solid state is likely determined by 
the steric hindrance of the TGT loop and, therefore, by the space group of the 
crystal (Padmanabhan, et al., 1996; Russo Krauss, et al., 2012). Interestingly, 
modifications that lower the symmetry of the two TT loops (mTBA, HD1ΔT3, 
HD1ΔT12) differentiates the energetics of the two modes of binding, thus pre-
sumably leading to a different population of the two species in solution. In all 
these cases, in the solid state the unmodified TT loop (T3T4 in HD1ΔT12; 
T12T13 in mTBA and in HD1ΔT3) targets the same thrombin region, referred 
to as A-region. This observation indicates that the difference in the binding af-
finity between the A- and B-regions towards the intact TT loop is more im-
portant than the packing interactions in which the TGT loop is involved. There-
fore, it is reasonable to conclude that the binding mode found in the crystal 
structure of the complexes between thrombin and the aptamer mutants is repre-
sentative of that adopted by the most abundant species in solution. From these 
data it emerges the existence of a sort of hierarchy among the interactions that 
govern the recognition process between thrombin and HD1 and that the binding 
could be improved by increasing the contacts of the nucleotide with the B-
region. In this perspective, the presence of two lysine side chains (Lys81 and 
Lys110) at a distance of about 10 Å from the TT loop interacting with the B-
region could be used to create new anchorage points of the aptamer on protein 
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surface. With this aim, proper modifications of T3 (or equivalently of T12) are 
under design. 
Improving aptamers by chemical modification  
Among the few chemical modifications that have led to an improvement of 
the binding properties of HD1, it is particularly interesting the replacement of 
nucleotide G8 with the modified nucleotide (R)-1-(4-(1-pyrenylethynyl) phe-
nylmethyl) glycerol (a.k.a. TINA), called HD1-r8p (Figure 10).  
 
Figure 10. Schematic representation of the modified HD1, HD1-r8p. 
The modification strongly improves the anticoagulant activity, affinity and 
thermal stability of HD1 (Rohrbach, et al., 2012). In the last months, I have 
been trying to determine the structure of HD1-r8p in complex with thrombin in 
order to establish the cause of such higher affinity with respect to its parent ap-
tamer. HD1-r8p has been provided by Prof. Gunter Mayer (University of Bonn, 
Germany) and Prof. Erik Pedersen (University of Southern Denmark, Den-
mark), with whom I started a collaboration.  
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MATERIALS AND METHODS 
Sample preparation 
Human D-Phe-Pro-Arg-chloromethylketone (PPACK) inhibited α-thrombin 
was purchased from Haemtech and the initial buffer was changed to 0.75 M 
NaCl using Centricon mini-concentrator (Vivaspin 500) and a refrigerated cen-
trifuge (Z216MK, Hermle Labortechnik).  
The two aptamers, lacking T3 (HD1ΔT3) and T12 (HD1ΔT12) nucleobase 
respectively, were synthesized by Nagatoishi et al. as previously described 
(Nagatoishi, et al., 2012). Each aptamer was dissolved in 10 mM potassium 
phosphate buffer pH 7.1 up to 2 mM concentration. Aptamer solutions were 
heated for 10 minutes at 85°C, slowly cooled down, and stored at 4°C over-
night. This annealing procedure is essential to induce the correct fold of the ap-
tamer. 
A standard protocol has been followed for the preparation of the complex 
between thrombin and each aptamer (Russo Krauss, et al., 2012). A two-fold 
molar excess of the annealed aptamer solution was laid on a frozen sample of 
thrombin and the sample left for three hours at 4°C. After complete melting, the 
solution was diluted and the buffer changed to 25 mM potassium phosphate 
buffer pH 7.1, 100 mM KCl. The solution was then extensively washed, in order 
to take off the excess of aptamer and finally concentrated to about 0.2 mM using 
Centricon mini-concentrator and a refrigerated centrifuge. 
Crystallization and data collection 
Initial crystallization trials, involving screening around the conditions previ-
ously used for crystal growth of thrombin complexes with HD1 (Russo Krauss, 
et al., 2012) or mTBA (Russo Krauss, et al., 2011), were unsuccessful. Subse-
quent sitting-drop crystallization experiments were set up, for all the three com-
plexes prepared, at 20°C in 96-well plates (Greiner Bio-One, USA) using an 
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Automated Protein Crystallization Workstation (Hamilton Robotics) and precip-
itant solutions of commercially available crystallization screens (Hampton Re-
search Crystal Screen 1, Crystal Screen 2 and Index). Optimization of promising 
conditions by fine-tuning pH, precipitant and additive concentration (Russo 
Krauss, et al., 2010) resulted in the growth of good diffraction-quality crystals 
of the complexes. 
In particular, thrombin-HD1ΔT3 crystals grew from 60% (v/v) Tacsimate 
pH 7, 1-3% (w/v) MPEG 5K or PEG 8000, while those of thrombin-HD1ΔT12 
from 25% (w/v) PEG 3350, 0.1 M Bis/Tris pH 5.8, 0.2 M ammonium acetate. In 
both cases concentration of the complex was about 0.2 mM. Optimization of 
crystallization conditions produced well-diffracting crystals using the hanging 
drop vapor diffusion method, at a protein-to-reservoir solution ratio of 1:1 in 1 
µL drops and using a protein concentration of about 0.2 mM. 
After the addition of 35% glycerol to the harvesting solution, crystals were 
flash-cooled at 100 K in super-cooled N2 gas produced by an Oxford Cryosys-
tem and maintained at 100 K during data collection. Diffraction data were col-
lected by using synchrotron light (λ = 1.2651 Å) and a Dectris Pilatus 2M detec-
tor on the XRD1 beamline 5.2 at Elettra Synchrotron Radiation Facility (Trieste, 
Italy). Data were indexed, processed and scaled with HKL2000 (Otwinowski, et 
al., 1997).  
Thrombin-HD1ΔT3 crystallizes in the monoclinic space group P21, with 
two molecules of the complex in the asymmetric unit, whereas thrombin-
HD1ΔT12 crystals belong to the triclinic space group. Detailed data collection 
statistics are reported in Table 2. 
Structure determination and refinement 
Initial phases were determined by molecular replacement method using 
Phaser (McCoy, et al., 2007), using the whole thrombin-HD1 complex (PDB 
entry 4DII) as search model. Crystallographic refinement was performed using 
CNS (Brunger, et al., 1998) and REFMAC5 (Vagin, et al., 2004), while manual 
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model building using Coot (Emsley, et al., 2010). After the inclusion of low-
resolution data and bulk solvent correction, the final R/Rfree were 0.155/0.190, 
for thrombin–HD1ΔT12, and 0.168/0.227, for thrombin–HD1ΔT3. For the lat-
ter structure, in the last steps of refinement the restraints arising from the non-
crystallographic symmetry were added. The protein geometry of the refined 
structures was monitored using PROCHECK (Laskowski, et al., 1993). Statis-
tics and parameters of the refinement are given in Table 2. The drawings were 
prepared with Pymol (Schrodinger, 2010). The coordinates of the structures 
were deposited in the Protein Data Bank with codes 4lz1 and 4lz4. 
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Table 2. Data collection and refinement statistics. Values in parentheses refer to the last resolution 
shell. 
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CHAPTER II – HD22: WHEN A G-QUADRUPLEX IS 
NOT ENOUGH 
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INTRODUCTION 
Polynucleotide backbone is characterized by an intrinsic large flexibility 
that allows the chain to reach a variety of three-dimensional shapes. In addition 
to the nucleobase sequence, the selection of a specific form is also dependent on 
the environmental parameters in which the nucleotide is embedded, such as pH, 
ionic strength, types of ions, temperature, etc. For this characteristics, the nucle-
otide scaffold can be easily designed to specifically interact with a variety of 
binding pockets on large receptors or even to bind and transport small metabo-
lites. Cooperative effect resulting from internucleobase interactions, however, 
are particularly important in determining the stabilization of a sequence of spe-
cific conformations along the chain that produces a particular motif such as the 
duplex motif, or the variety of quadruplex motifs, or even a more complex com-
bination of these motifs. While detailed studies of RNA and DNA aptamers 
with a single structural motif have been performed, up to now only very little is 
known about the structure of aptamers in which more than one motif can be 
found. 
Several examples of aptamers that are supposed to adopt a mixed du-
plex/quadruplex structure have been reported in the literature (Tasset, et al., 
1997; Chinnapen, et al., 2002; Pileur, et al., 2003; Mori, et al., 2004; Chou, et 
al., 2005; Gatto, et al., 2009; Li, et al., 2009). In all the above mentioned cases 
the presence of both structural motifs is required for strong and specific binding 
of the target. Both duplex and quadruplex are characterized by a large difference 
in shape and electrostatic potential. For example, with respect to a double helix, 
a G-quadruplex exhibits a substantially higher negative charge density, that 
have implications on the specificity in target recognition. To date, no crystallo-
graphic data exist on bimodular aptamers (i.e. aptamers that have a fold in 
which more than a motif coexist) or on their complexes with targets. Their in-
terest lies in the fact that they exhibit efficient recognition for a variety of tar-
gets related to severe pathologies or disorders, such as AIDS (Pileur, et al., 
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2003), rheumatoid arthritis (Mori, et al., 2004), hepatitis (Jones, et al., 2006), 
and thrombosis (Tasset, et al., 1997; Russo Krauss, et al., 2013), as well as to 
endogenous small molecules such as nicotinamide (Lauhon, et al., 1995), thy-
roxin (Levesque, et al., 2007), and hemin (Chinnapen, et al., 2002). Only re-
cently the structure of an RNA molecule with a mixed duplex/quadruplex fold 
in complex with a peptide from the human fragile X mental retardation protein 
has been solved by NMR (Phan, et al., 2011).  
One of the most interesting results of SELEX protocols directed towards 
human α-thrombin (thrombin) is the identification of potent second-generation 
aptamers that are supposed to adopt a mixed duplex/quadruplex conformation 
(Tasset, et al., 1997). In particular this family of aptamers includes a 29-mer, 
named HD22[29] (5’-AGTCCGTGGTAGGGCAGGTTGGGGTGACT-3’), and 
a 27-mer (HD22[27]), which lacks the first and the last residue with respect to 
the 29-mer. A schematic model of HD22[27] is shown in Figure 11.  
(a) 
 
(b) 
 
Figure 11. Schematic representations of the HD22[27] organization (a) as proposed by (Tasset, et 
al., 1997) and (b) as found in the crystal structure of the complex with thrombin. Hydrogen bonds 
between bases are represented by dotted lines (dashed lines represent G–G interactions). 
Both aptamers embody a 15-residue sequence very similar to that of the best 
characterized thrombin aptamer HD1 (5’-GGTTGGTGTGGTTGG-3’) and bind 
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thrombin with higher affinity (Kd ≈ 0.7 nM) (Tasset, et al., 1997) compared to 
HD1 (Kd ≈ 100 nM) (Macaya, et al., 1993). Several evidences indicate that 
HD22 aptamers recognize exosite II rather than exosite I (Tasset, et al., 1997). 
However, high resolution structural data on these aptamers and their complexes 
with thrombin are still lacking.  
Throughout this PhD project only the HD22[27] has been used. In particu-
lar, this work has been focused on the structural analysis of the thrombin-
HD22[27] complex both in solution and in the crystalline state. Furthermore, a 
solution study of the free aptamer has been performed by spectroscopic tech-
niques. The X-ray model of the thrombin-HD22[27] complex reveals interesting 
new features regarding the overall fold of the aptamer and the way it interacts 
with its target.  
RESULTS 
Crystal structure of thrombin-HD22[27] complex 
Best crystals of the complex between thrombin and HD22[27] diffract X-
rays to 2.4 Å resolution and belong to monoclinic space group P21. Electron 
density maps calculated from initial phases obtained by molecular replacement, 
using thrombin as search model, allowed unambiguous building of the whole 
aptamer. For what concerns thrombin, the heavy chain (residues 16-245) and the 
light chain (residues 1B-14K) were well-defined in the electron density map, 
with the exception of the γ-autolysis loop (residues 146-150) of the heavy chain. 
Crystallographic analysis shows that HD22[27] aptamer binds the thrombin 
molecule in the exosite II region forming a 1:1 complex (Figure 12). 
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Figure 12. Overall structure of the complex between thrombin and HD22[27]. Surface representa-
tion of the complex, with thrombin colored blue and HD22[27] colored orange. 
Interestingly, the ligand does not adopt a simple duplex or quadruplex fold, 
but it shows a mixed structure (Figure 11b). The crystal structure was refined to 
R/Rfree values of 0.181/0.249.  
A novel duplex-quadruplex motif 
The X-ray analysis of HD22[27] in complex with thrombin reveals that the 
oligonucleotide fold (Figure 1b and Figure 3a) is considerably different from the 
proposed and widely accepted model (Tasset, et al., 1997; Spiridonova, et al., 
2003; Hasegawa, et al., 2008; Müller, et al., 2008; Mayer, et al., 2009; Zhou, et 
al., 2010; Marson, et al., 2012) reported in Figure 1a.  
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(a) 
 
(b) 
 
(c) 
 
(d) 
 
Figure 13. Crystal structure of the HD22[27] aptamer. (a) Cartoon representation: the duplex re-
gion is colored green, the G-core cyan, the loops pink, the connecting residues blue and the 
bulged-out thymine orange. (b) A different view of the pseudo-G-quadruplex architecture. Fo-Fc 
unbiased OMIT simulated-annealing maps contoured at the 3.0 σ level are shown for the duplex 
motif (c), and for the G-tetrad (d). 
As expected, residues 1-3 and 25-27 form the duplex motif; however, with 
respect to the proposed model, the crystal structure contains the additional C4-
G23 Watson-Crick base pair (Figure 13a). This is favored by the bulging out of 
T24, which is inserted into a pocket on the thrombin surface (see below). The 
duplex structure is followed by sixteen residues (sequence number 5-20) orga-
nized in a G-tetrad core capped by the two-residue loops T9-A10 and T18-T19 
on one side, and the three-residue loop G13-C14-A15 on the opposite side 
(Figure 13b). Electron density maps corresponding to the two structural motifs, 
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duplex and quadruplex, are shown in panels c, d, and e of Figure 13. It has to be 
noted that on the basis of the sequence alignment between HD22[27] and HD1 
the G-quadruplex arrangement was expected to involve the fifteen residues 7-
21. The shape of the HD22[27] G-tetrad core is roughly similar to that of HD1, 
with the extra residue T6 forming an additional one-residue loop adjacent to the 
three-residue loop (Figure 11b and Figure 13b). However, the chain topology is 
markedly different. In the core region the four guanines G8, G11, G17, G20 
form a canonical G-tetrad (Figure 13d and Figure 14a): it presents the classical 
alternation of syn and anti conformations of the guanine residues (with G8 and 
G17 adopting the anti conformation and G11 and G20 adopting the syn confor-
mation) and the nucleobases are only slightly tilted out from the average plane 
of the tetrad. The remaining tetrad (Figure 14b) begins with G5, two residue up-
stream from the corresponding tetrad in the Tasset model (Figure 11). is located 
two residues upstream with respect to the putative HD1 sequence. This tetrad 
does not possess the canonical anti-syn-anti-syn but an anti-syn-anti-anti pattern 
of glycosidic angles (only G12 adopts a syn conformation). Moreover, the pres-
ence of a short one-residue loop slightly pushes apart the backbone atoms of G5 
and G7 causing the break of the Hoogsteen hydrogen bond cyclic pattern. Thus, 
the four guanine residues G5, G7, G12 and G16 can be better described as form-
ing two pairs: in one pair G5 and G16 are linked through a reversed Hoogsteen 
N2-N7 hydrogen bond, whereas in the second pair only a loose polar contact be-
tween O6 (G12) and N7 (G7) is present (Figure 14b). Despite these modifica-
tions, an almost perfect stacking of G5 and G20 (Figure 14c) and of G16 and 
G17 (Figure 14d) is observed. The latter pair also makes a good stacking inter-
action with Ade15 belonging to the three-residue loop. This unusual four gua-
nine set has been named pseudo-G-tetrad and the overall organization of resi-
dues 5-20 pseudo-G-quadruplex. Interestingly, base pairing is also observed for 
residues of the loops. In particular, T6-A15 form a trans Watson-
Crick/Hoogsteen pair (Figure 14e), and A10–T19 a trans Watson-
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Crick/Watson-Crick pair (Figure 14f). The sharp transition from the duplex mo-
tif to the pseudo-G-quadruplex one produces a somewhat strained kink of the 
molecule (Figure 3a). Indeed, G5, which is the first residue of the pseudo-G-
quadruplex segment, is also linked to C4, the last residue of the duplex. Thus, 
G5 can be seen as the pivot residue that mediates the conversion from a duplex 
to a quadruplex arrangement. In the facing strand, the hinge segment between 
the two motifs includes two residues: G22, which does not interact with other 
residues of the aptamer, and G21, which forms a G-fork with G5 (Figure 14g). 
As result of the different number of residues involved in the loops connecting 
the duplex-quadruplex structures the helical axes of the two motifs form an an-
gle of approximately 90°. Interestingly, no electron density assignable to a cati-
on is observed in this pseudo-G-quadruplex region. 
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(b) 
 
(c) 
 
(d) 
 
(e) 
 
(f) 
 
 (g) 
 
Figure 14. Snapshots of aptamer structural motifs. (a) G-tetrad, (b) pseudo-G-tetrad, (c) and (d) 
stacked bases, (e) trans Watson–Crick/Hoogsteen pair, (f) trans Watson–Crick/Watson–Crick pair 
and (g) G-fork. All the distances are reported are in Å. 
Interaction with thrombin 
The unusual mixed structure of HD22[27] extensively adheres to thrombin 
surface (Figure 12). In particular, the aptamer binds at exosite II burying a total 
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of 1118 Å2 of the protein accessible surface. Interaction between HD22[27] and 
thrombin involves numerous residues of both molecules: T9, T18, T19, G20, 
G23, T24, C27 and marginally G21, G22 and A26 of the aptamer, and segments 
89-101, 230-245 of thrombin, with a further contribution from residues Leu130, 
Arg165 and Lys169. A few examples of the contacts between thrombin and 
HD22[27] is are presented in Figure 15.	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(a) 
 
(b) 
 
(c) 
 
(d) 
 
Figure 15. Some examples of the interactions between thrombin and HD22[27] focusing on T9 
(a), G20 (b), G25 and C27 (c). (d) Insertion of HD22[27] T24 into a pocket on the thrombin sur-
face. The aptamer residue is represented as sticks and the thrombin molecule as a surface. All the 
distances are reported are in Å. 
As expected on the basis of the strong electropositive potential of exosite II, 
many polar contacts are observed at the interface. In particular, ion pairs are 
formed between the phosphate backbone of the nucleotide and positive charged 
residues of thrombin. Hydrophobic contacts, mainly involving loop residues T9, 
T18 and T19 and A26, also contribute to the stability of the complex. A further 
anchorage is represented by T24, which bulges out from the duplex region of 
the nucleotide into a protein pocket (Figure 15) where it is mainly involved in 
polar contacts.	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The thrombin-HD22[27] complex has been compared with two other 
thrombin-aptamer complexes: that with HD1 (PDB entry 4dih), which binds at 
exosite I, and that with Toggle-25t (PDB entry 3dd2), an RNA aptamer that em-
bodies two short duplex regions (Long, et al., 2008) and binds at exosite II. In 
particular, using Cocomaps tool (Vangone, et al., 2011), the protein-aptamer in-
terfaces have been compared (Table 3).  
Table 3. Thrombin-aptamer interface features.  
 
The much higher affinity of HD22[27] (Tasset, et al., 1997) with respect to 
HD1 (Macaya, et al., 1995; Nagatoishi, et al., 2011), which binds at exosite I, 
correlates very well with the almost doubled value of the interface area and of 
the number of interacting residues displayed by the HD22[27] complex. A simi-
lar good correlation is also found when the comparison is performed with Tog-
gle-25t that recognizes exosite II with a Kd of about 3 nM (Long, et al., 2008).  
Circular dichroism study  
Conformation and thermal stability of HD22[27] were investigated by 
means of circular dichroism in different experimental conditions. In particular, 
the role of monovalent cations on the folding of the aptamer was monitored. In 
the presence of sodium ions, the CD spectrum shows (Figure 16) two overlap-
ping positive signals at ~288 nm and ~260 nm and a negative band at ~240 nm, 
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which do not correspond to a canonical G-quadruplex arrangement. A different 
behavior is observed for solutions containing potassium ions: the spectrum 
shows an intense positive peak at 292 nm, a less intense positive peak at about 
250 nm, and two deep wells at 265 and 235 nm, respectively.  
 
Figure 16. CD spectra of HD22[27] in the presence of sodium before (bold line) and after (dashed 
line) the addition of thrombin. 
These spectral features are typical of antiparallel G-quadruplexes. These da-
ta suggest that the aptamer can adopt two different conformations, denoted as M 
(sodium containing samples) and T (potassium containing samples). The ther-
mal stability of the two nucleotide folds has also been investigated in the 10-
90°C range. The results indicate that the transition temperature (Tm) is signifi-
cantly lower for the M conformer (Tm = 36°C) with respect to the T conformer 
(Tm = 47°C). The influence of thrombin binding on the aptamer structure and 
stability has also been analyzed. CD measurements were performed after addi-
tion of an equimolar amount of protein to the solutions of the nucleotide con-
taining either sodium or potassium ions. The thrombin addition induces only 
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small variations to the spectral features of the oligonucleotide (Figure 16), but 
significantly increases the stability of the aptamer both in the M and in the T 
conformation, as indicated by their Tm values (48.0 and 57.0°C, respectively). A 
similar thrombin-induced stabilization effect was previously observed in the 
case of HD1 (Nagatoishi, et al., 2011; Russo Krauss, et al., 2012). 
It should be noted that all the crystallization trials carried out using the ap-
tamer in the T conformation failed.  
DISCUSSION 
Duplex-quadruplex motif and thrombin exosite II 
The crystallographic analysis of the complex with thrombin shows that 
HD22[27] adopts a novel, sharply kinked, conformation, in which the helical 
axis of the regular duplex segment and that of the pseudo-G-quadruplex motif 
are approximately at right angle. The resulting overall shape of the molecule al-
lows both motifs to interact with the protein (see below). The pseudo-G-
quadruplex segment lacks the stabilizing effects produced by cyclic Hoogsteen 
hydrogen bonds in one of the two tetrads and by the cation binding 
(Williamson, 1994), but preserves the base stacking among the guanines of the 
core (panels c and d of Figure 14). Indeed, although the pivot residue G5 is dis-
placed from the position required for the formation of a canonical G-tetrad, the 
anti conformation of this residue efficiently places the base in a position to build 
up the close packing of the eight guanine bases of the core. Moreover, hydrogen 
bonds between bases of loops (panels e and f of Figure 14) also contribute to the 
intramolecular stabilization of this fold. Thus, it may be surmised that the ap-
tamer conformation found in the crystal structure of the complex with thrombin 
represents one of the low-energy conformations adopted by the free nucleotide.  
Protein-aptamer interaction shows interesting new features. In the known 
crystallographic structures of HD1 complexes (Russo Krauss, et al., 2011; 
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Russo Krauss, et al., 2012) the formation of the complex is essentially driven by 
the TT loops of the quadruplex. By contrast, in the present structure the protein 
recognition involves an extended region of the aptamer that includes the duplex 
segment (G23, A26, C27), the bulged out residue T24, the pseudo-G-
quadruplex core (G20), as well as the quadruplex connecting loops (T9, T18, 
T19). Despite the lack of a well-defined binding structural motif (such as the TT 
loops of HD1), this large contact area (1118 Å2) displays high complementarity 
with the thrombin surface. Indeed, the surface complementarity index 
(Lawrence, et al., 1993) is 0.65, a value only slightly lower than the ones in the 
range 0.72-0.76 calculated for the complexes of HD1 family, in which the con-
tact area is much smaller (560 Å2). 
Circular dichroism studies indicated that oligonucleotides embodying du-
plex-quadruplex domains display a large conformational variability (Zhou, et 
al., 2010; Lin, et al., 2011; Zavyalova, et al., 2011; Dolinnaya, et al., 2012; 
Marson, et al., 2012) depending on the experimental conditions, such as the na-
ture and concentration of salts, temperature, pH, etc. In order to establish a cor-
relation between solution and solid state structure, the crystallographic analysis 
has been complemented with a CD study. Comparison between CD spectra of 
HD22[27] free and in complex with thrombin (see methods for details) indicates 
that the binding does not produce significant modifications on aptamer spectral 
features, but enhances its thermal stability. Similar results were obtained in the 
case of HD1 (Nagatoishi, et al., 2011; Russo Krauss, et al., 2012). This finding 
supports the hypothesis that the crystal structure is representative of the aptamer 
conformation in solution. 
In particular, the aptamer shows a spatial organization that differs from the 
proposed model and widely accepted (Tasset, et al., 1997; Spiridonova, et al., 
2003; Hasegawa, et al., 2008; Müller, et al., 2008; Mayer, et al., 2009; Zhou, et 
al., 2010; Marson, et al., 2012), such as the one sketched in Figure 11a that is 
characterized by a definite separation between the duplex and the quadruplex 
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regions. On the contrary, in the X-ray structure the duplex is directly enchained 
to a pseudo-G-quadruplex topology never observed before. This structural ar-
rangement optimizes the adhesion of HD22[27] on thrombin exosite II. Circular 
dichroism (CD) measurements also suggest that the crystal structure is repre-
sentative of the solution structure of the aptamer in the presence of sodium. 
In the absence of crystallographic data on the T conformation of the ap-
tamer, the CD features have been interpreted on the basis of the literature data 
on bimodular nucleotides. The CD spectrum of the T conformation is similar to 
those of HD1-like aptamers, with peaks characteristic of an antiparallel G-
quadruplex fold. In agreement with the current literature models, it may be 
speculated that this form includes a duplex segment separated by a two- three-
residue linker from a canonical G-quadruplex. The latter is indeed particularly 
stabilized by K+, in line with the features of the CD spectra recorded for 
HD22[27] in the presence of potassium.  
The existence of two HD22[27] conformers would explain also the results 
of the crystallization experiments. The failure of the trials carried out using 
HD22[27] in the T conformation may indicate that the spatial separation of the 
two folding motifs does not allow an efficient binding at exosite II. Moreover, 
the presence of a canonical G-quadruplex with exposed TT and TA loops may 
favor the binding of HD22[27] at exosite I, similar to that observed for HD1. 
CONCLUSIONS AND FUTURE PERSPECTIVES 
Aptamers targeting exosite II 
In the last years several attempts to improve the biological activity of 
thrombin binding aptamers via chemical and structural modifications have been 
performed (Müller, et al., 2007; Müller, et al., 2008; Pasternak, et al., 2011; 
Musumeci, et al., 2012; Rangnekar, et al., 2012). The present contribution based 
on a combined crystallographic and spectroscopic study provides the scientific 
 58 
community with an enhanced structural and conformational knowledge of bi-
modular aptamers that will serve as a platform for a rational design of modified 
molecules for use in anticoagulant therapies and diagnostic applications. In par-
ticular, the structural results emphasize the role of residues controlling the spa-
tial transition from the duplex to the quadruplex architecture and the recruitment 
of both motifs in thrombin binding. 
On more general grounds, the behavior of HD22[27] indicates that bimodu-
lar oligonucleotides should not be thought as fixed, structured building blocks 
linked together. Their intrinsic structural plasticity makes them multifaceted lig-
ands able to assume different folds depending on even small variations of envi-
ronmental parameters.  
Finally, the turn of the oligonucleotide chain that originate the sharp transi-
tion from the duplex to the pseudo-quadruplex motif may represent an intri-
guing example of the way in which a double helix can evolve in a duplex-
quadruplex structure, such as that found in the biologically relevant regions of 
nucleic acids. 
MATERIALS AND METHODS 
Sample preparation 
Human D-Phe-Pro-Arg-chloromethylketone (PPACK) inhibited thrombin 
was purchased from Haemtech and the initial buffer was changed to 0.75 M 
NaCl using Centricon mini-concentrator (Vivaspin 500) and a refrigerated cen-
trifuge (Z216MK, Hermle Labortechnik).  
The aptamer HD22[27] was purchased from Sigma-Aldrich. Stock solutions 
were prepared by dissolving the lyophilized oligonucleotide at a concentration 
of 4 mM in 10 mM sodium phosphate buffer at pH 7.1. Aptamer solutions were 
heated for 10 minutes at 85°C, slowly cooled down, and stored at 4°C over-
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night. This annealing procedure is essential to induce the correct fold of the ap-
tamer. 
A standard protocol has been followed for the preparation of the complex 
between thrombin and each aptamer (Russo Krauss, et al., 2012). A two-fold 
molar excess of the annealed aptamer solution was laid on a frozen sample of 
thrombin and the sample was left for three hours at 4°C. After complete melt-
ing, the solution is diluted and the buffer changed to 25 mM sodium phosphate 
buffer pH 7.1, 0.1 M NaCl. The solution was then extensively washed, in order 
to take off the excess of aptamer and finally concentrated to about 0.2 mM using 
Centricon mini-concentrator and a refrigerated centrifuge. 
Crystallization and data collection 
Initial crystallization trials, involving screening around the conditions previ-
ously used for crystal growth of thrombin complexes with HD1 or mTBA , were 
unsuccessful. Subsequent sitting-drop crystallization experiments were set up, 
for all the three complexes prepared, at 20°C in 96-well plates (Greiner Bio-
One, USA) using an Automated Protein Crystallization Workstation (Hamilton 
Robotics) and precipitant solutions of commercially available crystallization 
screens (Hampton Research Crystal Screen 1, Crystal Screen 2 and Index). Op-
timization of promising conditions by fine-tuning pH, precipitant and additive 
concentration (Russo Krauss, et al., 2010) resulted in the growth of good dif-
fraction-quality crystals. 
Best crystals of thrombin-HD22[27] complex grew from solutions contain-
ing 14-16% (w/v) of PEG 3350 and 0.2 M sodium citrate. Optimization of crys-
tallization conditions produced well-diffracting crystals using the hanging drop 
vapor diffusion method, at a protein-to-reservoir solution ratio of 1:1 in 1 µL 
drops and using a protein concentration of about 0.2 mM. 
After the addition of 35% glycerol to the harvesting solution, crystals were 
flash-cooled at 100 K in super-cooled N2 gas produced by an Oxford Cryosys-
tem and maintained at 100 K during data collection. Diffraction data were col-
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lected by using synchrotron light (λ = 1.2651 Å) and a Dectris Pilatus 2M detec-
tor on the XRD1 beamline 5.2 at Elettra Synchrotron Radiation Facility (Trieste, 
Italy). Data were indexed, processed and scaled with HKL2000 (Otwinowski, et 
al., 1997).  
Thrombin-HD22[27] crystals belong to the monoclinic space group P21 and 
diffract up to 2.4 Å resolution. In this case, the Matthews coefficient calcula-
tions suggested the presence of a 1:1 complex in the asymmetric unit. Detailed 
data collection statistics are reported in Table 4. 
Table 4. Data collection statistics. Values in parentheses refer the highest resolution shell. 
 
Structure determination and refinement 
The structure of the complex between HD22[27] and thrombin was solved 
by molecular replacement method using the program Phaser (McCoy, et al., 
2007) with the coordinates of both inhibited thrombin (derived from the struc-
ture of its complex with HD1; PDB entry 4dih) and a DNA duplex (derived 
from the structure of a DNA dodecamer duplex; PDB entry 1lu5) as search 
models. To avoid bias, PPACK, ions and water molecules were removed from 
the starting model. A clear solution was obtained with a log-likelihood gain 
(LLG) of 1511. The model was subjected to few cycles of rigid body refinement 
followed by several cycles of coordinate minimization and B-factor refinement 
using CNS (Brunger, et al., 1998) and REFMAC5 (Vagin, et al., 2004). Each 
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run was alternated with manual model building using Coot (Emsley, et al., 
2010). Fourier difference maps, calculated with (Fo–Fc) and (2Fo–Fc) coeffi-
cients, showed continuous electron density in proximity of the DNA duplex 
segment. The analysis of these maps, calculated at various stages of refinement, 
allowed the building of the whole aptamer molecule, as well as the fitting of 
PPACK in the active site, the identification of the protein glycosylation site, and 
the positioning of several water molecules. After inclusion of low resolution da-
ta and bulk solvent correction, the crystallographic R/Rfree for the final model 
of the complex between thrombin and HD22[27], in the resolution range 50.0-
2.40 Å, were 0.181/0.249. At the end of refinement the geometry of the protein 
structure was monitored using PROCHECK (Laskowski, et al., 1993) and 
WHATCHECK (Hooft, et al., 1996). A full list of refinement statistics is re-
ported in Table 5. The drawings were prepared with Pymol (Schrodinger, 2010). 
The coordinates of the structure have been deposited in the Protein Data Bank 
with code 4i7y.  
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Table 5. Summary of refinement statistics. 
 
Circular Dichroism 
Circular dichroism (CD) spectra were recorded at 10°C using a Jasco J-710 
spectropolarimeter equipped with a Peltier thermostatic cell holder (Model 
PTC-348WI). CD measurements were carried out in the 200-350 nm range us-
ing a 0.1 cm path length cell and 40 µM solutions of the free aptamer. Before 
measurements, the instrument was calibrated with an aqueous solution of D(+)-
10-camphorsulfonic acid at 290 nm and the samples were pre-equilibrated at 
10°C for 5 minutes.  
Thermal unfolding curves were recorded in the 10–90°C range, in 1°C steps 
with 0.5 minute equilibration time between readings, at heating rate 1°C/min. 
Transition temperatures were calculated from the second derivative of the ellip-
ticity change vs temperature.  
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STATE OF THE ART 
Protein-protein recognition is a critical event in a large number of cell pro-
cesses. In fact, in biological systems proteins rarely act in isolation but they bind 
other biomolecules to elicit specific cellular responses (Jones, et al., 1995; 
Marianayagam, et al., 2004). In particular, the self-association of proteins to 
form dimers and higher-order oligomers is a very common phenomenon in na-
ture. Protein-protein interactions form the basis of the quaternary structure of 
multimeric proteins, and represent one of the most complex levels of structural 
organization in biological molecules. Multimeric proteins represent just one sys-
tem in which protein-protein interactions are important and interactions have 
been studied in many protein-inhibitor, protein-ligand and antibody-antigen 
complexes (Janin, et al., 1990). However, it has been shown that the interactions 
between subunits in dimeric proteins are amongst the strongest and most exten-
sive (accessible surface area up to about 5000 Å2 per subunit).  
Among the variety of mechanisms by which protein oligomerization has 
evolved, an interesting role is played by 3D domain swapping. It is a mecha-
nism by which two monomer exchange (swap) an identical structural domain to 
form dimers or higher-order oligomers. In a 3D domain-swapped dimer, a do-
main of one subunit replaces the identical domain of the other subunit, and vice 
versa, restoring all the interaction already present in the monomers. According 
to Eisenberg’s definitions (Bennett, et al., 1995; Schlunegger, et al., 1997), the 
interface between domains that exists in both the monomer and the dimer is 
termed closed interface (C-interface) and the interface that is present only in the 
dimer is termed open interface (O-interface). However, the segments that links 
the two domains (hinge loops) present a different conformation for the mono-
mer and the dimer (Figure 17). 
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Figure 17. Closed monomers are comprised of tertiary or secondary structural domains (repre-
sented by circle and square) linked by polypeptide linkers (hinge loops). The interface between 
domains in the closed monomer is referred to as the C- (closed) interface. Closed monomers may 
be opened by mildly denaturing conditions or by mutations that destabilize the closed monomer. 
Open monomers may dimerize by domain swapping. The domain-swapped dimer has two C-
interfaces identical to those in the closed monomer, however, each is formed between a domain 
from one subunit (black) and a domain from the other subunit (gray). The only residues whose 
conformations significantly differ between the closed and open monomers are in the hinge loop. 
The interface that does not exist in the closed monomers is referred to as O- (open) interface. 
To date, despite numerous efforts, no unifying molecular mechanism of do-
main swapping has emerged. What seems clear is the existence of distinct in-
termediates, in which some hydrophobic part of the monomeric protein becomes 
ex-posed and, thereby, is available for interaction with a ‘like’ molecule 
(Gronenborn, 2009). 
It has been speculated about the possibility that 3D domain swapping could 
be a dimerization mechanism for all proteins with free N- and C- termini 
(Bennett, et al., 1995). This elegant mechanism of protein oligomerization has 
an increasing frequency in the literature, but its biological significance remains 
still unclear. For example, enzymatic proteins could use 3D domain swapping 
for functional regulation, in particular in allostery, which involves multiple ac-
tive sites. It could also rescue protein function after deleterious mutation 
(Chirgadze, et al., 2004). So far, however, it appears that 3D domain swapping 
is predominantly connected with molecular pathology, through its involvement 
in conformational disorders, of which amyloid aggregation is perhaps the most 
important (Janowski, et al., 2001; Knaus, et al., 2001; Bennett, et al., 2006; Liu, 
et al., 2011).  
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Over the years many proteins have been found to be domain-swapped. 
However, bovine pancreatic ribonuclease (RNase A) has represented and it still 
represents a suitable model system for the study of such mechanism. It is well-
known that the first hypothesis of exchange of N-terminal regions was based on 
biochemical experiments performed on this protein (Crestfield, et al., 1963). 
RNase A was also the first protein showing the possibility to exchange different 
regions of the polypeptide chain, giving rise to a number of experimental and 
modeling studies to characterize multimeric assemblies (Liu, et al., 2002a; Liu, 
et al., 2002b). Upon lyophilization from acetic acid, RNase A forms two differ-
ent swapping dimers: in one dimer (C-Dimer) the two C-terminal β-strands are 
swapped (Liu, et al., 2001), whereas in the other (N-Dimer) the N-terminal α-
helices (Liu, et al., 1998) are swapped. The two dimers have different quater-
nary structures: the N-Dimer presents a very compact structure, whereas the C-
Dimer shows a very loose O-interface. Moreover, with the same procedure, oth-
er high-order RNase A oligomers are generated (trimers, tetramers, etc.). Each 
oligomeric species exists in the form of at least two conformational isomers 
(Gotte, et al., 1999). 3D domain swapping has been found to endow oligomers 
with additional properties besides the basal enzymatic activity (Liu, et al., 
1998). Indeed, oligomeric forms of RNase A have generated great interest as 
engineered therapeutics, as they, in contrast with monomeric RNase A, show 
antitumor activity (even if mild). Different members of the pancreatic-type ri-
bonuclease family are able to acquire oligomeric swapped forms. Gaining a bet-
ter understanding of the mechanism by which these aggregates form is im-
portant not only for understanding the process of domain swapping but also for 
improving methods by which to engineer stable oligomeric forms. Furthermore 
these studies of oligomers of well-characterized RNases may illuminate the 
formation of amyloid and other protein aggregates. 
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CHAPTER III – DOMAIN SWAPPING: GIVING 
SOMETHING TO TAKE “SOMETHING ELSE” BACK 
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INTRODUCTION 
Bovine seminal ribonuclease (BS-RNase) holds a unique position in the 
RNase A family since it is the only covalent dimeric member. Native BS-RNase 
is an equilibrium mixture of swapped (MxM) and unswapped (M=M) isoforms 
(Piccoli, et al., 1992), whose subunits are linked by two intersubunit disulphide 
bridges formed by Cys31 of one subunit and Cys32 of the other, and vice versa. 
The MxM form, which is further stabilized by additional non-covalent interac-
tions between the two subunits through the swapping of the N-terminal α-
helices, displays a potentially therapeutic cytotoxic activity for tumor cells 
(Matousek, 1973; Kim, et al., 1995). This peculiar property has been related to 
the shape (Sica, et al., 2004) and stability (Giancola, et al., 2011) of its non-
covalent swapped dimeric derivative (NCD-BS), which can be obtained upon 
selective reduction of the two MxM interchain disulphide bridges (Piccoli, et 
al., 1992). Indeed, it has been shown that in reduction conditions, as those found 
in the cytosol, the MxM isoform is converted in the NCD form whose quater-
nary structure is very similar to that of MxM (Sica, et al., 2004) and prevents 
the binding with the Ribonuclease Inhibitor (RI), a protein very abundant in the 
cytosol of mammalian cells. It is worth to note that RI binds with very high af-
finity RNase A (Lee, et al., 1989) as well as other monomeric, pancreatic-like, 
RNases (Kobe, et al., 1993; Kobe, et al., 1996). 
Studies on dimeric variants of RNase A, obtained by introducing in its se-
quence residues playing a key role in the acquisition of the BS-RNase 3D do-
main-swapped structure, have confirmed the strict relation between antitumor 
activity and NCD-BS quaternary architecture. Indeed, none of these dimeric 
variants retains in its non-covalent form a compact quaternary structure able to 
evade RI (Merlino, et al., 2009b). This result well correlates with the much low-
er cytotoxic activity of these RNase A variants as compared to that of BS-
RNase (Ercole, et al., 2009). BS-RNase and RNase A share more than 80% of 
the primary structure and a strictly conserved three-dimensional fold 
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(Spadaccini, et al., 2012), but they have a completely different behavior with 
respect to the swapping process. In particular, up to now there has been no ex-
perimental evidence of C-swapped BS-RNase dimers. For this reason it was be-
lieved that, in contrast to RNase A, the C-swapping was precluded for the BS-
RNase sequence, due to the presence of a lysine residue replacing asparagine 
113 in the C-terminal hinge region (residues 111-116). However, very recently, 
experimental evidences of the formation of BS-RNase derivatives stabilized by 
the C-terminal swapping have been shown (Gotte, et al., 2012).  
In this PhD project, the first clear experimental evidences on the formation 
of a C-terminal swapped dimer of the monomeric BS-RNase derivatives, after 
incubation in acetic acid and lyophilization, have been produced. The crystallo-
graphic model of one of these dimers has revealed a quaternary structure differ-
ent with respect to that adopted by the CD-RNase A that well correlates with the 
data on the stability against dissociation of this dimer. 
RESULTS 
Solution studies 
Monomeric samples of BS-RNase with the cysteine residues 31 and 32 al-
kylated with iodoacetamide have been incubated in 40% acetic acid for one hour 
at room temperature and lyophilized. In a typical experiment, 10 mg of protein 
are dissolved in 2.0 mL of a solution of 40% acetic acid, at a final concentration 
of 5 mg/mL. After overnight lyophilization, the protein is dissolved either in 50 
mM Tris/HCl buffer pH 7.3, 0.13 M NaCl or in 0.2 M phosphate buffer pH 6.7 
and loaded on a G-75 column (equilibrated with the same buffer) and eluted at 
4°C. The chromatographic pattern is reported in Figure 18 (dashed line). Peak 
integration revealed that more than 60% of the protein is eluted as monomer, 
whilst the remaining part corresponds to aggregated forms of different size, alt-
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hough the relative amount of each aggregate varied slightly with the elution 
buffer.  
 
Figure 18. Chromatographic pattern of a gel-filtration on Sephadex G-75 upon acetic acid incuba-
tion and lyophilization of the monomeric derivatives of STAA-BS-RNase, PALQ-BS-RNase, and 
BS-RNase. 
From the elution volume it is possible to calculate that the first peak corre-
sponds to the size of a tetramer, the second (indicated as TART) to the size of a 
trimer, and the third (indicated as DART) to the size of a dimer. The remaining 
part, equivalent roughly to the 10% of the total, corresponds to higher-size ag-
gregates. The dimer accounts for about 20-25% of the total protein amount.  
The same experiment has been performed for the STAA-mBS mutant, ob-
taining the chromatographic profile also reported in Figure 18 (solid line), 
which closely resembles the one obtained with the parent (wild-type) protein, 
except for the slightly higher amount of aggregates. The fractions corresponding 
to the artificial dimers of both BS-RNase and STAA-BS-RNase have been 
pooled and a small amount of these protein samples has been loaded on a poly-
acrylamide gel run under native conditions (pH 4.5). Aliquots of BS-RNase and 
of NCD-BS together with the monomeric forms of BS-RNase and STAA-BS-
RNase (mBS and STAA-mBS) were also loaded on the gel (Figure 19). 
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Figure 19. Polyacrylamide gel-electrophoresis under native conditions of the dimeric forms ob-
tained by incubation in acetic acid followed by lyophilization of the monomeric derivatives of BS-
RNase and STAA-BS-RNase (mBS and STAA-mBS) (lanes 5 and 6). The corresponding mono-
meric forms (lanes 1 and 2), together with BS-RNase (lane 3) and NCD-BS, obtained by selective 
reduction of the swapped dimer (lane 4), are also reported for comparison. 
The analysis of the gel indicated clearly that BS-RNase and NCD-BS (lanes 
3 and 4) are characterized by a single band. On the contrary, both the artificial 
dimers (lanes 5 and 6) showed the presence of a significant amount of the corre-
sponding monomeric forms (lanes 1 and 2), which necessarily had to be pro-
duced upon dissociation of the dimeric species after the gel-filtration and, in 
part, even while running the gel. Interestingly, the comparison of lanes 3 and 4 
with 5 and 6 indicates that the artificial dimers migrate on the gel with a mobili-
ty very close to that of NCD-BS, thus suggesting the presence of a single dimer-
ic form even in the samples prepared by acetic acid lyophilization, in contrast 
with the results obtained for RNase A. It is indeed well-known that the two di-
mers formed when RNase A is subjected to the same treatment can be separated 
by cathodic gel-electrophoresis (Gotte, et al., 1999). 
The fast dissociation of the artificial dimers indicated by the gel-
electrophoresis prompted a further characterization of their stability in solution. 
Therefore, a comparison of the dissociation processes of the NCD forms of BS-
RNase and STAA-BS-RNase with the corresponding artificial dimers, i.e. DART-
BS and DART-STAA-BS has been performed. The proteins have been incubated 
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at 37°C and, at regular time intervals, aliquots corresponding to 0.2 mg of each 
sample were loaded on Superdex 75 to evaluate the relative amount of dimer 
and monomer. Surprisingly, the kinetic stability of the two artificial dimers was 
found significantly lower than that of the corresponding NCD forms: the t1/2 of 
the artificial dimers were 1.5 hours for DART-BS and 0.6 hours for DART-STAA-
BS, while the values of the partner NCDs, measured in the same experimental 
conditions, were 6.1 hours and 2.2 hours, respectively (Table 6). 
Table 6. Half-life times t1/2 of dimers from dissociation experiments. 
 
These results suggest that the two dimeric forms obtained in different exper-
imental conditions, i.e. the NCDs and the artificial dimers, have different qua-
ternary structures. Interestingly, the two variants conserved the same relative 
stability, with the STAA mutant displaying the faster dissociation rate. 
A deeper comparison of the behavior of NCD and DART dimers has been per-
formed for the STAA-BS-RNase variant, by measuring the dissociation rate at 
different temperatures. Straight lines were obtained at all the temperature ex-
plored (in the range 15-37°C), confirming the homogeneity of all the protein 
samples. Furthermore, the Arrhenius plot of the kinetic constants allowed the 
calculation of the activation energy of the dissociation process, reported in Ta-
ble 6, which were 92.2 Kcal/mol and 56.8 Kcal/mol for NCD and DART, respec-
tively. 
These results clearly indicated that NCD and DART dimers have different 
quaternary structures, and consequently different stabilities, in solution. Howev-
er, the fast dissociation of the artificial dimers prevented any further characteri-
zation in solution.  
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Crystal growth 
The extensive search for crystallization conditions has produced different 
results in the case of the native enzyme and of its STAA variant. Crystals of 
DART-BS grew in a very short time (about 12 hours), showed an even shorter 
lifetime (about 10 hours), were quite disordered and their diffraction power de-
cayed after few minutes of X-ray exposure. As a consequence, only few diffrac-
tion images were recorded. In the case of DART-STAA-BS, the higher stability of 
the crystals allowed a complete X-ray diffraction data collection at 2.48 Å reso-
lution. Unfortunately, in addition to their low diffraction power, essentially due 
to their high solvent content (about 60%), crystals are twinned by pseudo-
merohedry (see section Materials and Methods of this chapter). 
Crystallographic analysis 
The features of DART-STAA-BS crystals (low diffraction power and twin-
ning) made both solution and refinement processes not trivial. The structure was 
solved by molecular replacement using the BS-RNase monomer as a search 
model (PDB entry 1n1x). The asymmetric unit contains two protein chains, 
whose position and orientation are compatible with the swapping of their C-
terminal arms. The structure was refined at 2.48 Å resolution to R/Rfree values 
of 0.170/0.186 and the final model includes 1889 protein atoms and 35 water 
molecules. The average B-factor computed for all protein non-hydrogen atoms 
is 16.4 Å2. A full list of refinement statistics is reported in Table 7, and the crys-
tallographic structure of DART-STAA-BS is reported in Figure 20. 
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Table 7. Data collection and refinement statistics. Values in parentheses refer to the highest reso-
lution shell. 
 
The quality of the electron density maps allowed a detailed description of 
nearly the whole molecule. The two chains share an almost identical structure, 
as judged from their very low root mean square deviation (RMSD) of 0.4 Å 
(RMSD calculated for main chain atoms excluding residues 111-116). No major 
topological variation has been found in the common ribonuclease fold adopted 
by each subunit (defined as the structural unit formed by residue 1-110 of one 
chain, the core of the protein, and residues 117-124 of the other chain, the 
swapped domain). Indeed the RMSD between one of the two subunits and the 
monomeric enzyme (PDB entry 1n1x) is ~0.7 Å (RMSD calculated for main 
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chain atoms of residues 1-110 and 117-124). A phosphate ion is bound to each 
composite catalytic site stabilizing the dimer by mimicking the enzyme sub-
strate, as typically observed in several other ribonuclease structures (Liu, et al., 
2001; Merlino, et al., 2005b; Merlino, et al., 2008; Merlino, et al., 2009a; 
Merlino, et al., 2012). 
 
Figure 20. Crystallographic structure of DART-STAA-BS represented as cartoon. The two chains 
are colored differently to highlight the C-terminal swapping. 
The electron density associated with the hinge region (residues 111–116), 
which connects the swapped domain to the rest of the protein, is continuous for 
the A subunit (Figure 21a) but less well-defined in the case of the B subunit. 
The conformation of segment 111A-116A is stabilized by a strong intra-chain 
H-bond between the side chains of K113 and S115 (Figure 21b).  
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(a) 
 
(b) 
 
Figure 21. (a) Structure of the hinge peptides of DART-STAA-BS. Distances are reported in Ang-
strom. Chain A is colored blue while chain B is colored orange. (b) 2Fo-Fc electron density map of 
the hinge peptide of chain A contoured at 1.0 σ. 
None of the two hinge peptides adopts the  β-sheet conformation shown by 
the same regions in the CD-RNase A structure. In the latter, the N113 enforces 
the hydrogen bonding network in the  β-sheet alignment of the two hinge pep-
tides. In the seminal enzyme the presence of a lysine in that position replaces 
the stabilizing H-bond with a positive charge repulsion. Moreover, the muta-
tions of glutamic acid 111 with glycine and tyrosine 115 with serine confer a 
much higher flexibility to this region in the structure of the C-dimer of BS-
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RNase when compared to that of CD-RNase A, as indicated by the low defini-
tion of the electron density of the B subunit hinge peptide, and thus to the whole 
swapped dimer. As a consequence, in the case of DART-STAA-BS there is a de-
crease in the number of the inter-hinge contacts. It has to be noticed that in the 
case of the C-swapped dimers of both RNases the only additional interactions 
formed upon domain swapping (open interface) involve residues of the hinge 
peptides. In particular, the swapped dimer is stabilized by the burying at the in-
terface between the two hinge peptides of an area of about 390 and 520 Å2 for 
DART-STAA-BS and CD-RNase A, respectively (Figure 21b). The peculiar 
structural features of the hinge segments produce a quaternary organization of 
DART-STAA-BS very different from that of CD-RNase A (Liu, et al., 2001). In-
deed, after superposition of one subunit of each dimer, a further rotation of 
about 150° has to be applied in order to best overlap the second subunits (Figure 
22).  
 
Figure 22. Comparison of the overall structures of DART-STAA-BS (in blue) and CD-RNase A (in 
red). Only one subunit (composed by residues 1-110 of chain A and residues 117-124 of chain B) 
of each dimer has been superposed; a further 150° rotation is needed to best superpose the second 
structural units (residues 1-110 of chain B and residues 117-124 of chain A) of the two dimers. 
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DISCUSSION 
The comparison of the swapping properties of RNase A and BS-RNase can 
provide interesting clues to investigate the 3D domain swapping mechanism and 
its functional implications. Despite the high similarity of their amino acid se-
quence (more than 80% identity), the two proteins have a completely different 
behavior with respect to the swapping (Sica, et al., 2004; Picone, et al., 2005; 
Merlino, et al., 2008; Merlino, et al., 2009b; Merlino, et al., 2012). This has 
been confirmed by the crystallographic model of DART-STAA-BS. In BS-RNase 
the exchange of the C-terminal arms between the two subunits produces a qua-
ternary organization very different with respect to that observed in the case of 
CD-RNase A (the RNase A dimer obtained by the swapping of the same struc-
tural elements). This variation is mainly due to the change in the structure 
adopted by the hinge peptides (111-116) of the two enzymes. In particular, a 
key role is played by the lysine residue at position 113. On this respect, it is 
worth to mention here that the lyophilization from acetic acid of the monomeric 
variant of BS-RNase where lysine 113 was replaced with asparagine, i.e. the 
residue present at the same position in RNase A, produces a higher amount of 
the C-terminal swapped dimer and other multimers in comparison with the wild-
type enzyme (Gotte, et al., 2012). The substitution also results in an increased 
stability of the oligomeric forms (Gotte, et al., 2012). The other two substitu-
tions present in the hinge peptide of the seminal enzyme, E111G and Y115S, 
confer a high conformational flexibility to this region, facilitating the dissocia-
tion of the dimer in solution. 
Interestingly, no traces of a N-terminal swapped (artificial) dimer of BS-
RNase and STAA-BS-RNase have been found in our experimental conditions. 
This unexpected result could be due to a quick dissociation of the dimer or to a 
very high energy barrier separating the monomer from the NCD form. The ex-
perimental conditions, in turn, could push the refolding pathway towards the 
formation of the C-swapping dimer, which is formed more easily despite its low 
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stability, and represents the highest quantity (about 16%) among the aggregated 
forms recovered from the size exclusion chromatography.  
As far as the biological implications are concerned, unfortunately the fast 
dissociation of the artificial dimers in solution hampered a functional characteri-
zation, although it is possible to foresee that they should be devoid of any sig-
nificant antitumor activity. Indeed, modeling studies indicate that the X-ray 
structure of DART-STAA-BS fits nicely in the RI cavity, as shown in Figure 23, 
thus reducing the high potential associated with 3D domain swapping.  
 
Figure 23. Putative model of the complex between the ribonuclease inhibitor (PDB entry 1z7x) 
and DART-STAA-BS in two different orientations. 
Based on these considerations, it can be inferred that the C-swapping of BS-
RNase represents an unfavorable event with respect to the N-swapping, there-
fore the substitutions of E111, N113, and Y115 of RNase A with G111, K113 
and S115 in BS-RNase should be considered a favorable event in the evolution, 
since they reduce the effects of C-terminal swapping. Finally, these data enforce 
the role of the disulphide bridges linking the two subunits of BS-RNase, which 
prepare the N-terminal swapping (Mazzarella, et al., 1995) and facilitate its oc-
currence under mild physiological conditions, giving the right orientation to the 
subunits. 
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MATERIALS AND METHODS 
Protein production and purification 
Monomeric and dimeric forms of BS-RNase, as well as its mutant 
G16SN17TP19AS20A (STAA-BS-RNase), have been kindly provided by the 
group of Prof. Picone, Department of Chemical Sciences, University of Naples 
“Federico II”, prepared and purified as described in (Ercole, et al., 2003; 
Picone, et al., 2005; Ercole, et al., 2007). 
The non-covalent dimeric forms of BS-RNase and of its mutant STAA-BS-
RNase have been obtained by following two different protocols. The non-
covalent dimer obtained by selective reduction of the swapped isoform (MxM) 
of the covalent dimer are referred to as NCD-BS-RNase and to NCD-STAA-
BS-RNase, respectively. Non-covalent dimers obtained by lyophilization upon 
40% acetic acid incubation of the monomeric derivatives (mBS-RNase and 
STAA-mBS-RNase) are referred to as artificial dimers (DART). The monomeric 
forms are both obtained by iodoalkylation of cysteine residues 31 and 32 by io-
doacetamide (IAA), as reported elsewhere (Merlino, et al., 2012). In both cases 
the dimers were purified at 4°C by Size Exclusion Chromatography (SEC) of 
Sephadex G-75 (1.5 x 72 cm). 
Cathodic non-denaturing polyacrylamide gel-electrophoresis was performed 
at pH 4.5, following the protocol described in (Gotte, et al., 2012). 
Dissociation studies 
The dissociation kinetics of the dimers has been analyzed following the 
amount of dimeric and monomeric proteins as a function of the incubation time 
at different temperatures, as previously reported (Merlino, et al., 2012). At regu-
lar time intervals, aliquots of the protein samples were loaded on a Superdex 75 
HR 10/30 column on FLPC system (Pharmacia, Uppsala, Sweden) equilibrated 
and eluted in 0.1 M Tris/HCl pH 7.3, 0.13 M NaCl. 
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Crystallization and data collection 
Solutions of purified DART obtained from mBS (DART-BS) and STAA-mBS 
(DART-STAA-BS) at concentration of about 20 mg/mL in 25 mM sodium phos-
phate pH 6.7 have been used to search for the crystallization conditions. Initial 
screening has been carried out using Hampton Research Crystal Screen 1, Crys-
tal Screen 2, Index, SaltRx and PEG/Ion at 20°C by the hanging-drop and sit-
ting-drop vapor-diffusion methods. Drops consisting of 0.5 µL protein mixed 
with an equal volume of precipitating solution were equilibrated against 500 µL 
of reservoir solution. Best crystals of DART-BS have been grown by using a crys-
tallization solution containing 36-40% w/v PEG4K, 0.1 M lithium chloride, 
while crystals of DART-STAA-BS have been obtained in 0.1 M sodium caco-
dylate buffer pH 6.2 or 16-20% w/v PEG35K, 0.2 M lithium chloride, 0.1 M 
sodium cacodylate buffer pH 6.0 and 3% v/v acetonitrile.  
X-ray diffraction data have been collected at 100 K at the ELETTRA Syn-
chrotron (Trieste, Italy) using a 165 mm CCD detector from MAR-Research. 
Diffraction data have been processed using the program suite HKL2000 
(Otwinowski, et al., 1997). A summary of the indicators commonly used to es-
timate the quality of datasets is given in Table 7. Pseudo-merohedral twinning 
(twin law h,-k,-h-l and twin fraction 0.49) have been detected using phe-
nix.xtriage from the Phenix suite (Adams, et al., 2010). 
Structure determination and refinement 
The structure of DART-STAA-BS has been solved by molecular replacement 
using the structure of BS-RNase monomeric derivative (PDB entry 1n1x) as a 
search model. The refinement has been carried out with REFMAC5 (Vagin, et 
al., 2004) and Phenix (Adams, et al., 2010). Several alternating cycles of posi-
tional refinement, energy minimization, individual temperature factor refine-
ment and manual model building have been performed. Model rebuilding has 
been carried out using Coot (Emsley, et al., 2010). The program PROCHECK 
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(Laskowski, et al., 1993) was used to analyze the quality of the final structures. 
The refinement statistics are presented in Table 7. Figures have been drawn us-
ing Pymol (Schrodinger, 2010). 
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CHAPTER IV – TOO MUCH IS A BAD THING 
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INTRODUCTION 
A striking case of intermolecular interaction is given by protein molecules 
that can produce large aggregates through a self-association process, that even-
tually become insoluble and precipitate. The formation of aggregates by numer-
ous proteins and peptides unrelated in sequence, structure, and function suggests 
that the propensity to aggregate is an innate property of polypeptides (Dobson, 
2004; Rousseau, et al., 2006). Proteins occur in vivo in many cases at concentra-
tions above their critical concentration for aggregation (Baldwin, et al., 2011), 
but energy barriers against aggregation keep them in a metastable soluble state 
(Buell, et al., 2012). Understanding the molecular determinants behind biologi-
cal aggregation has been one of the major goals of structural biologists for the 
last thirty years. Protein deposits are the hallmark of several severe human dis-
eases, including Alzheimer’s, Parkinson’s, and Huntington’s diseases or type 2 
diabetes (Dobson, 2001). Amyloidoses, for example, are a range of clinical dis-
orders caused by extracellular deposition of β-sheet-rich elongated, unbranched 
fibrils, known as amyloids, derived from aggregation of misfolded or partially 
unstructured peptides and proteins (Pepys, 2006). Sometimes amyloidoses are 
referred to as “conformational diseases” in order to emphasize that the aggrega-
tion pathway occurs via a conformational change, which induces the formation 
of non-native interactions between adjacent protein molecules (Carrell, et al., 
1997). However, not all reported aggregates and fibrils are enriched in β-sheet-
structure (Dykes, et al., 1978; Lomas, et al., 2002) or they are associated with 
deposition diseases (Holmes, et al., 1990; Downing, et al., 1999). 
Three main mechanisms exist by which proteins can specifically self-
associate to form fibrils: cross β-spine (Nelson, et al., 2005), end-to-end stack-
ing (Harrington, et al., 1997; Elam, et al., 2003), and 3D domain swapping 
(Bennett, et al., 2006; Guo, et al., 2006). Although cross β-spine aggregation 
has drawn most of the attention of the scientific community, end-to-end stack-
ing is the mechanism by which notable proteins do aggregate. The two cases of 
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sickle cell hemoglobin (Harrington, et al., 1997) and SOD1 (Elam, et al., 2003) 
are the best-known.  
As already described above, 3D domain swapping gives rise to dimer having 
two structural units that are very similar to the monomeric species and formed 
by residues from the two protein chains. Such a dimer is referred to as closed-
ended as there are no unsatisfied (exposed) domains. The open interface is the 
additional interface not presence in the monomer and unique in the dimeric spe-
cies. Open-ended runaway swapped oligomers can also form by consecutive ex-
change of the swapped domain of three or more monomers. The hypothesis that 
open-ended runaway swapping is implicated in the formation of protein fibrils 
has been supported by the observation that human prion protein (Knaus, et al., 
2001), cystatin C (Janowski, et al., 2001), and  β2-microglobulin (Liu, et al., 
2011), which form fibrils related to diseases, are domain-swapped.  
Even closed-ended swapped dimers do have structural features that facilitate 
aggregation. Indeed, the stability of these dimers is mostly guaranteed by the 
closed interface that pre-exists in the monomeric form. Moreover some extra-
stability is gained upon generation of the open interface, which is usually less 
important, as the two structural units are often linked by two flexible hinge pep-
tides. Therefore, in contrast with common protein dimers that have acquired the 
quaternary organization through the development of an extensive open interface, 
the domain-swapped dimers are often endowed with a larger freedom in their 
quaternary assembly (Merlino, et al., 2005a). This feature may greatly facilitate 
self-recognition processes and make these dimers more prone to association. 
Part of this PhD project has been focused on the characterization of a variant 
of human pancreatic ribonuclease (desHP), forced to swap by deleting five resi-
dues (16-20) in the loop linking the N-terminal segment (residues 1-15) to the 
core of the protein (Russo, et al., 2000). The segment is partially folded as an α-
helix and embodies some residues important for the constitution of the active 
site (His12 and Asn13). In the variant this helix cannot take over the position 
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occupied in the wild type enzyme and it remains exposed to the solvent, eventu-
ally promoting the formation of a stable closed-ended swapped dimer, whose 
specific activity is virtually identical to that of the monomeric wild-type enzyme 
(Russo, et al., 2000). The structural characterization by X-ray crystallography 
reveals that desHP molecules give rise to a densely packed rod-like structure, 
which extends infinitely along one crystallographic axis. On the basis of this ar-
rangement the formation of fibrils in solution has been predicted and indeed ob-
served. 
RESULTS 
desHP overall structure 
desHP was crystallized and diffraction data were collected up to a resolution 
of 2.70 Å. The crystal belongs to space group P212121. The molecular replace-
ment approach produced a plausible solution with 4 copies of the monomeric 
search model in the asymmetric unit and a very high solvent content (about 
60%) that could explain, at least in part, the poor diffracting power of the crys-
tal. 
The final model, which includes 3836 protein atoms, 211 water molecules 
and 13 sulfate ions, has been refined to R/Rfree values of 0.199/0.248. The sta-
tistics of refinement are listed in Table 8. 
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Table 8. Data collection and refinement statistics. Values in parentheses refer to the highest reso-
lution shell.  
 
In order to facilitate reading, residue numbering of the parent protein (wild-
type human pancreatic ribonuclease) has been adopted; therefore, in the present 
case, Ser15 is covalently linked to Ser21. The monomers are associated as N-
terminal swapped dimers with approximate two-fold symmetry. In each dimer, 
residues 1-14 of one chain and residues 24-125 of the partner chain form a 
structural unit (SU) that closely resemble the native enzyme (PDB entry 1e21); 
with respect to the latter the RMSD based on Cα of the four SU is in the range 
0.30-0.35 Å.  
Each active site is assembled with residues of the two chains and is practi-
cally indistinguishable from that of the wild-type enzyme (Figure 24).  
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Figure 24. A composite active site generated by residues belonging to subunits A and B of one of 
the two dimers in the asymmetric unit. The electron density map is calculated with 2Fo-Fc Fourier 
coefficients and is contoured at the 2.2 σ level. 
The swapping is associated with a four residues long hinge peptide, whose 
conformational features control the quaternary assembly of the dimer by deter-
mining the relative orientation of the N-terminus with respect to the body of the 
chain. The two dimers have slightly different quaternary structures; this is 
shown in Figure 25a, where the two dimers are drawn after superposition of one 
SU. The rotation that has to be applied to best superpose the second SU of the 
two dimers amount to 23° and is achieved with a modest energy penalty through 
very small variations of main chain torsion angles of the four hinge residues.  
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Figure 25. (a) View of the two dimers in the asymmetric unit with monomers A and C (purple) 
superposed. A further 23° rotation is needed to best superpose the second monomers of the two 
dimers: B (red) and D (blue). For clarity, the hinge peptides have not been drawn. (b) The struc-
ture of a domain-swapped dimeric mutant of human pancreatic ribonuclease (PDB entry 1h8x; 
Canals et al., 2001) is shown as a cartoon for comparison with the desHP dimers. (c) The two di-
mers in the independent unit are shown as cartoons: chains A (red) and B (blue) form the first di-
mer and chains C (green) and D (yellow) form the second dimer. 
In both dimers the position of Asp14 is mostly unperturbed by the swap-
ping: the carboxylate group and the carbonyl oxygen are hydrogen bonded to 
the side chain of Tyr25 and His48, respectively, of the partner chain; these in-
teractions are typical features of pancreatic-like monomeric ribonucleases. The 
carboxylate group also makes a further hydrogen bond with Oγ of Ser21. The 
polyserine stretch (Ser15, Ser21, Ser22, Ser23), which constitutes the hinge 
loop, forms a rather regular three-fold helix stabilized by internal hydrogen 
bonds. In comparison, the swapped dimer (PM8) of a mutated form of the hu-
man pancreatic ribonuclease (Canals, et al., 2001), shown in Figure 25b, has a 
more opened structure and the two SU are further apart with respect to both 
desHP dimers due to the greater length of the hinge peptide. The association of 
the two dimers (formed by chains A-B and C-D) in the asymmetric unit is also 
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shown in Figure 25c. Interestingly, the extension of the open surface (about 390 
Å2 and 255 Å2 for the two dimers, respectively) is much smaller than that be-
tween dimers (see below). It should be noted that both dimers display a pseudo-
two-fold symmetry, whose axis is approximately orthogonal and almost inter-
sects the crystallographic screw axis parallel to c. 
Supramolecular assembly 
The molecular packing displays particularly interesting features. The two 
dimers are related by an approximate rotation of 90° about an axis that is practi-
cally coincident with the crystallographic two-fold screw axis parallel to the c 
axis, combined with a c/4 screw translation. These symmetry operators, together 
with the two-fold symmetry of the dimers, build up rods parallel to the c axis 
with an approximate 4322 symmetry. The interdimer association is very strong, 
burying a surface of about 900 Å2 (930 Å2 and 820 Å2 for the two crystallo-
graphically independent dimer-dimer interfaces) that propagates along the c axis 
producing tightly packed rods. By contrast, contacts between rods are weak 
(Figure 26). 
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Figure 26. View of the rod structure along the a axis. The rod on the left is colored green. In the 
central rod, each chain of the two dimers in the asymmetric unit has a different color according to 
the color code used in Figure 25c. In the third rod, the chains are colored to highlight the antipar-
allel double-helical arrangement of the monomers. 
Sulfate anions  
Thirteen sulfate anions have been identified in the electron density map of 
the asymmetric unit of the crystal, confirming that this ion plays a fundamental 
role in the crystallization process. With the exception of the anions positioned at 
the four active sites, as already observed for many others structures of RNases 
(Vitagliano, et al., 1999; Vitagliano, et al., 2000), all the remaining ones are lo-
cated on positive patches of the rod surface. The electrostatic features of the sur-
face calculated with the software APBS (Baker, et al., 2001) and the bound ani-
ons is shown in Figure 27. 
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Figure 27. Electrostatic surface of the two dimers in the asymmetric unit. Sulfate ions are shown 
in ball-and-stick representation. 
In particular, four sulfates are bound at equivalent position of the four mon-
omers and interact with Arg32 and Arg33. Two more sulfate ions are located at 
nearly equivalent positions mediating the interaction between rods. The remain-
ing two ions are located at the border of the interdimer surfaces. Thus, the pres-
ence of sulfate ions may be important for the stabilization of such a positively 
charged rod-like structure. 
Solution study 
In solution desHP displays a strong tendency to aggregate, making difficult 
the growth of crystals suitable for X-ray diffraction. Indeed, at low ionic 
strength, the protein solution is opalescent even at very low concentration (1 
mg/mL). Increasing ionic strength (0.3 M in NaCl), it was possible to prepare a 
solution more concentrated in protein (up to 2 mg/mL) from which crystals were 
obtained. Moreover, a tendency to form fibrils is also suggested by the features 
of the observed crystal packing. Eventually, fibrils were grown by incubating a 
solution of the protein at 0.6 mg/mL concentration in 0.1 M Tris-acetate pH 7.1, 
0.2 M NaCl, both in the presence and in the absence of 0.1 M sodium sulfate, at 
room temperature for two weeks. Samples of the solution were deposited on a 
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mica surface, dried and washed with water (see section Materials and Methods 
of this chapter). The substrate was then imaged with an atomic force micro-
scope, using tapping mode in air. Several AFM images (Figure 28) clearly 
showed the presence of long fibrils with a highly homogeneous cross sectional 
diameter of about 18 ± 4 Å. 
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Figure 28. AFM images of desHP fibrils at low (a) and high (b) magnification. 
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In Figure 29, a histogram of the heights derived from the images is reported. 
Moreover, fibrils appear not to be twisted, in contrast to most amyloid fibrils 
described to-date (Figure 28b).  
 
Figure 29. Histogram of desHP fibril heights derived from AFM images. 
The ability of these fibrils formed in solution to bind ThT and to lead to the 
enhanced fluorescence emission at 480 nm upon excitation at 440 nm has also 
been tested. No difference in fluorescence signal was observed between a fresh 
protein solution and the fibril-containing solution (not shown).  
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DISCUSSION 
Although proteins can be robust against point mutations, enduring signifi-
cant numbers of amino acid substitutions with little changes in protein structure 
and function (Taverna, et al., 2002), it is not uncommon to find cases in which 
adding/deleting short fragments to/from their sequences partially destabilizes 
the native fold and favors the formation of dimers or higher-order structures. Ei-
senberg and co-workers converted RNase A in a protein able to form fibrils by 
simply expanding the hinge peptide connecting the core domain of the protein 
with the exchanging C-terminal β-strand, with an insertion of ten glutamine res-
idues (Sambashivan, et al., 2005). The designed amyloid-like fibrils of RNase A 
contain 3D domain-swapped molecules endowed with enzymatic activity. The 
β-sheet arrangement arises from stacking of the expanded hinge peptides. 
Here, it is shown that the deletion of five residues in the hinge loop of hu-
man pancreatic ribonuclease induces the formation of a domain-swapped dimer 
that leads to the generation of linear aggregates of desHP molecules, as revealed 
by the crystal packing, in which domain swapping and flexibility of the dimeric 
assembly are intimately involved. Domain swapping provides the cohesive in-
teraction energy for the formation of dimers through an extensive interchain 
closed interface, whereas the size of the open interface is often small; this fea-
ture confers flexibility to the quaternary structure, particularly when the hinge 
peptide is long, that facilitates self-recognition of the dimers and favors further 
aggregation. In this respect, the behavior of domain-swapped dimers is quite 
different from that of dimers whose quaternary structure is held together only by 
the interactions across an open interface; in this case the stability of the dimer 
relies on the extension of the interface and this necessarily produces a rather rig-
id quaternary assembly. In the present case, two dimers with slightly different 
quaternary structures are present in the crystal: their close interfaces are nearly 
the same and amount to about 1500 Å2, whereas the open interface is small and 
only slightly different (about 390 Å2 and 250 Å2, respectively). These two di-
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mers alternate on top of each other forming tightly packed rods, which sit on the 
crystallographic two-fold screw axis parallel to c. In the rod, the molecules form 
a left-handed helix with approximate four-fold symmetry. The small difference 
in the quaternary assembly of the dimers efficiently increases the complementa-
rity of the two crystallographically independent dimer-dimer contact surfaces 
that are 930 and 820 Å2, respectively. These tightly packed rods run side by side 
through the crystal with weak lateral contacts. The present case closely resem-
bles the one described for SOD1 (Elam, et al., 2003), in which the interfaces 
within dimers and between dimers along the rod axis are approximately similar 
and amount to about 650 Å2. These values are much higher in our case because 
the interface between dimers is about 50% higher and, most remarkably, the one 
stabilizing the dimeric form through domain swapping amounts to about 2000 
Å2. These data strongly underline the cooperative role between domain swap-
ping and stacking interactions in building up supramolecular structures. It 
should be also noted that desHP rods, as in the case of SOD1, are not formed by 
crystallographic operators only, but its generation involves a non-
crystallographic symmetry operation. This suggests that the formation of fila-
ments is not simply a necessary consequence of crystallization (Elam, et al., 
2003).  
Interestingly, each rod of desHP can also be alternatively described as 
formed by two intertwined antiparallel four-fold helices: one helix is formed by 
one of the monomers, monomer A, C, A*... of the dimers successively stacked 
along the rod, and the second helix is built up by monomers B, D, B*... of the 
same dimers, where the star indicates screw symmetry related units. Domain 
swapping between A and B, C and D..., cross-links monomers belonging to dif-
ferent helices and strongly stabilizes the whole structure. 
The crystal structure of desHP described in this work suggests that the pro-
tein could form fibrils in solution, and this prediction was confirmed by the ob-
servation of long, unbranched thin fibrils by AFM. Filaments of several mi-
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crometers in length were observed in different samples, and the thickness was 
measured (see histogram of fibril heights in Figure 29). 
Figure 30 shows a crystal plane perpendicular to the c axis; from the picture 
it is clear that fibrils are almost cylindrical in shape. A rough estimation of fibril 
width derived from the crystallographic model is about 25-30 Å. The diameter 
measured by AFM (≈20 Å) of these fibrils is smaller than the crystallographic 
dimensions suggest, a feature than can be explained by the fact that the AFM 
images of fibrils have been acquired in a dry state. The macromolecular crystal, 
on the other hand, is highly hydrated (about 60% of total volume) and more than 
200 water molecules have been found to interact directly with the protein.  
 
Figure 30. View of the structure along the crystallographic c axis. 
Based on the AFM images, which show substantial amounts of amorphous 
protein, it appears that only a small fraction of the protein sample is converted 
into fibrils, rendering further biophysical examination, for example by CD spec-
troscopy, difficult. However, the fact that the formation of long, unbranched fi-
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brils have been observed under quiescent conditions and at low concentrations 
suggests that these fibrils are indeed the same entities found in the crystal state. 
Moreover, the absence of enhanced ThT fluorescence strongly supports the hy-
pothesis that the fibrils observed are not cross-β rich amyloid fibrils but rather 
fibrils derived from the fibrillar assembly observed in the crystal.  
This result represents the first example of a structure-based prediction of 
protein fibril formation in solution, and in turn suggests that these fibrils can be 
modeled at atomic detail on the basis of the crystal structure. 
CONCLUSION 
3D domain swapping is a mechanism for forming elaborate, large assem-
blies that retain a protein’s original fold, referred to as native-like aggregation. 
In particular, the interplay between the interchain closed interface and the qua-
ternary structure flexibility, which are characteristic features of a swapping di-
mer, can play a crucial role in determining self-aggregation processes through a 
precise hierarchical organization of the native proteins. In this thesis, it has been 
shown how, starting from the observation of the peculiar supra-molecular as-
sembly found in the crystal, the formation of long and unbranched protein fibrils 
has been predicted and indeed observed. These results highlight the importance 
of domain swapping in inducing fibril formation by a mechanism alternative to 
the most common runaway swapping. 
MATERIALS AND METHODS 
Crystallization and data collection 
Protein production and purification were performed as described previously 
(Russo, et al., 2000). Crystals of desHP were obtained after one week at 4°C by 
the hanging drop vapor diffusion method, using 22% (w/v) PEG 8000 and 0.1 
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M ammonium sulfate as precipitants, protein concentration 1.6 mg/ml, in a 0.1 
M sodium citrate buffer pH 6.5.  
X-ray diffraction data were collected at 100 K at the ELETTRA Synchro-
tron (Trieste, Italy) using a 165 mm CCD detector from MAR Research. Dif-
fraction data were processed using the program suite HKL2000 (Otwinowski, et 
al., 1997). A summary of the indicators commonly used to estimate the quality 
of datasets is given in Table 8. 
Structure determination and refinement 
The initial phase determination was carried out by molecular replacement 
method using the program PHASER (McCoy, et al., 2007). The refined coordi-
nates of des(1-7)HP-RNase (PDB entry 1e21) were used as a search model 
(Pous, et al., 2001).  
The refinement was carried out with the programs CNS v1.3 (Brunger, et 
al., 1998) and REFMAC5 (Vagin, et al., 2004). Several alternating cycles of 
positional refinement, energy minimization, individual temperature factor re-
finement and manual model building were performed. Model rebuilding was 
carried out using Coot (Emsley, et al., 2010). Water molecules and sulfate ions 
were added manually into the model using the same software. The program 
PROCHECK (Laskowski, et al., 1993) was used to analyze the quality of the 
final structures. The refinement statistics are presented in Table 8. Pymol 
(Schrodinger, 2010) was used to draw figures. The final model and structure 
factors have been deposited in the Protein Data Bank (PDB entry 4kxh). 
Atomic Force Microscopy imaging 
A 10 μL drop of the protein solution (0.6 mg/mL) was deposited on a fresh-
ly cleaved mica, and let stand for about 30 minutes in air, then rinsed with Mil-
liQ water to remove unbound molecules and salt dissolved in the buffer. The 
remaining water was blown away with nitrogen. Atomic force microscopy was 
performed under ambient conditions in intermittent contact mode using a Nan-
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owizard II (JPK Instruments). Mikromasch NSC36 cantilevers with a resonant 
frequency in the range of 75-150 kHz and nominal spring constants of approx. 1 
N/m were used. Height images were recorded at 2048x2048 pixels resolution. 
The scan rate varied between 0.2 and 1.0 Hz. All image data sets were analyzed 
using Gwyddion AFM software. 
Fluorescence experiments 
The fluorescence spectra of solutions of 1.2 µM Thioflavin T (ThT) were 
measured with a UV/Vis fluorimeter (constant excitation wavelength 440 nm, 
emission scanned from 450 to 600 nm). Then, the fluorescence of a solution of 
0.6 mg/mL desHP fibrils in 0.3 M NaCl at pH 7.1 and 1.2 µM ThT was meas-
ured.  
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CHAPTER V – TWO IS BETTER THAN ONE 
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INTRODUCTION 
Ribonucleases (RNases) are potentially cytotoxic agents thanks to their abil-
ity to degrade RNA, and therefore to inhibit protein biosynthesis at both tran-
scriptional and translational levels (Ilinskaya, et al., 2005). The cytotoxic activi-
ty of RNases is critically dependent on the ribonucleolytic activity and on the 
ability of these molecules to reach the cytosol and to degrade RNA by evading 
the action of the ribonuclease inhibitor (RI) (Youle, et al., 1997; Leland, et al., 
2001a; Matousek, 2001; Makarov, et al., 2003; Dickson, et al., 2005). This in-
triguing feature has stimulated since many years numerous studies on the anti-
tumor effects of RNases, leading to a slow but continuous progress toward the 
development of ribonuclease-based cancer therapeutics. Engineering of these 
enzymes is actively pursued in order to increase their cytotoxicity and selectivi-
ty towards malignant cells (Leland, et al., 1998; Bretscher, et al., 2000; Leland, 
et al., 2001b; Dickson, et al., 2003). The great interest in this class of proteins is 
confirmed by the high number of patents and papers recently published in this 
field and by ongoing clinical trials (Raines, 2013). 
In the last decade, it has been shown that oligomerization is essential for 
providing special properties to RNases (Libonati, et al., 2004). For example, the 
human pancreatic ribonuclease (HP-RNase), a monomeric enzyme very sensi-
tive to RI inactivation, has been transformed into dimeric RNases, called HHP-
RNase and HHP2-RNase, selectively cytotoxic for malignant cell lines (Di 
Gaetano, et al., 2001; Merlino, et al., 2009a). Dimers of bovine pancreatic ribo-
nuclease (RNase A) formed by cross-linking with amine-reactive imido esters, 
inhibit tumor cell proliferation in vitro (Bartholeyns, et al., 1976) and in vivo 
(Tarnowski, et al., 1976; Bartholeyns, et al., 1979). Cross-linked trimers of 
RNase A generated with a dimethyl suberimidate linker displayed higher toxici-
ty towards a cervical carcinoma cell line with respect to the cross-linked dimers 
(Gotte, et al., 1997). RI-evasive trimeric conjugates of G88C RNase A and 
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G89C HP-RNase, prepared by using a thiol-reactive homo-bifunctional linker 
efficiently inhibit tumor growth in tumor-bearing mice (Rutkoski, et al., 2010).  
Domain-swapped ribonucleases represent a class of RNase oligomers de-
serving a special interest. In particular, domain-swapped oligomers of RNase A 
were shown to be selectively cytotoxic toward tumor cells. Purified RNase A 
domain-swapped dimers, trimers, and tetramers (Gotte, et al., 1999), obtained 
by lyophilizing the enzyme protein from 40% acetic acid solutions (Crestfield, 
et al., 1963), display antitumor activities that increase remarkably as a function 
of the oligomer mass and, at the same time, show a complete lack of embryotox-
icity (Matousek, et al., 2003). Unfortunately, the short half-life time of domain-
swapped oligomers hampers their use as cytotoxic agents. A peculiar example is 
given by BS-RNase (see Chapter III), that selectively kills human multidrug-
resistant neuroblastoma cells via induction of apoptosis and severely reduces the 
appearance of lung metastases generated from Lewis lung carcinoma cells in vi-
vo. The cytotoxic action of this enzyme is related to the survival of a non-
covalent swapped dimer in the cytosol (Piccoli, et al., 1992). This activity sig-
nificantly increases when the dimeric enzyme is transformed in tetramers by 
double domain swapping (Gotte, et al., 2012).  
In this PhD project, it has been tried to use the 3D domain swapping mecha-
nism to modulate RNase A self-assembly. The idea is to force the reciprocal ex-
change of polypeptide segments between two RNase A monomers by shortening 
the hinge peptide (also called hinge loop) connecting the N-terminal arm to the 
core of the protein. As illustrated in Chapter IV, this strategy has already been 
successfully applied to HP-RNase (Russo, et al., 2000). The aim is the genera-
tion of a stable dimer to be used as a building block to create higher-order oli-
gomers, with a longer half-life time and of defined subunit composition, stoi-
chiometry, and quaternary structure. In particular, as in the case of desHP, a var-
iant of RNase A (desBP) was forced to form a domain-swapped dimer by delet-
ing five residues (16-20) in the hinge loop. This line of research is still under-
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way and, at the moment, only a preliminary crystal structure of desBP has been 
obtained. The study of the oligomerization tendency of this dimer has revealed 
that under mildly denaturating conditions tetramers, and higher-order oligomers 
are formed. The final aim of the research is the structural characterization of the 
dimeric and tetrameric forms whose cytotoxic activity will also be analyzed. 
RESULTS AND DISCUSSION 
Overall crystal structure 
desBP was crystallized and diffraction data were collected up to a resolution 
of 1.78 Å. The crystal belongs to space group P21212. The asymmetric unit con-
tains two half-dimers, each located on a crystallographic two-fold axis. The sta-
tistics of data collection are listed in Table 9.  
Table 9. Data collection statistics. Values in parentheses refer to the highest resolution shell.  
Space	  group	   P21212	  Unit	  cell	  parameters	  (Å)	   a	  =	  66.5	  b	  =	  72.4	  c	  =	  52.8	  Resolution	  range	  (Å)	   50.0	  -­‐	  1.78	  (1.81	  –	  1.78)	  Measured	  reflections	   179381	  Unique	  reflections	   25149	  (1235)	  Rmerge	  (%)	   8.4	  (63.1)	  Mean	  I/σ(I)	   22.2	  (2.9)	  Completeness	  (%)	   99.8	  (100)	  Multiplicity	   7.1	  (7.2)	  Chains	  per	  asymmetric	  unit	   2	  
 
Refinement of the structure is still underway. One of the two reconstructed 
dimers in the asymmetric unit is shown in Figure 31. 
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Figure 31. A desBP dimer represented in a cartoon representation. 
As in the case of desHP (Pica, et al., 2013), in order to facilitate reading, 
residue numbering scheme of the wild-type RNase A has been kept; therefore, 
in the present case, Ser15 is covalently linked to Ser21. The unit composed by 
the core of one chain (residues from 24 to 124) and the swapped N-terminal he-
lix of the other chain (residues from 1 to 14) is defined as structural unit (SU). 
Thus, the four SU in the unit cell have the same folding of the wild-type parent 
protein, RNase A (PDB entry 1kf4). 
The two dimers of desBP (each generated by a binary symmetry operation) 
have approximately the same quaternary organization: if any two SU belonging 
to each dimer is superposed, then a rotation of about 2° (χ angle) would overlap 
the second SU. χ is a suitable parameter for comparing the quaternary structures 
between pairs of dimers.  
The quaternary organization of desBP has been compared to that of its hu-
man counterpart, desHP (PDB entry 4kxh), as well as to that of the N-terminal 
swapped dimer of wild-type RNase A (ND-RNase A), obtained upon lyophiliza-
tion from acetic acid (PDB entry 1a2w) and the non-covalent swapped dimer of 
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BS-RNase (PDB entry 1tq9). The value of χ for each pair of dimers analyzed is 
reported in Table 10.  
Table 10. χ angle for pair of N-terminal domain-swapped dimers of several pancreatic-like ribo-
nucleases. The two crystallographically different dimers of desBP and desHP are arbitrarily de-
noted as desBP1, desBP2, desHP1, and desHP_2. 
	   desBP1	   desBP2	   desHP1	   desHP2	  ND-­‐RNase	  A	  desBP1	   -­‐	   	   	   	   	  desBP2	   1.7°	   -­‐	   	   	   	  desHP1	   8.2°	   9.1°	   -­‐	   	   	  desHP2	   18.3°	   19.2°	   22.6°	   -­‐	   	  ND-­‐RNase	  A	   119.1°	   119.8°	   111.5°	   126.3°	   -­‐	  NCD-­‐BS	   95.0°	   95.1°	   101.6°	   80.2°	   160.2°	  
 
From the comparison of the χ values reported in Table 10, it appears clear 
that the quaternary organization of desBP is much more similar to that of desHP 
rather than ND-RNase A. The shortening of five residues in the sequence of 
RNase A, as well as in that of HP-RNase, leads to the lost of degrees of freedom 
in the respective swapped dimers, which is thus characterized by a lower con-
formational flexibility with respect to the swapped dimers formed by the wild-
type proteins. The lower conformational flexibility constrains, in some extent, 
the two dimers towards a common quaternary organization. 
Despite this similarity in the overall organization desBP shows a completely 
different crystal packing with respect to desHP, as well as a different solubility 
in solution. As already stated in Chapter IV, desHP has a great tendency to ag-
gregate and, in fact, it forms fibrils in solution and it is organized as rod-like 
structures in the crystalline state. desBP is much more soluble than its human 
counterpart.  
Oligomerization studies 
desBP has been lyophilized from 40% acetic acid in order to promote the 
swapping of its C-terminal tail, thus leading to the formation of oligomers in 
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which the central subunits swap both their N- and C-terminal tails while the lat-
eral subunits swap only their N-terminus. Preliminary results showed that te-
tramers, hexamers, and higher-order oligomers migrate differently on a cathodic 
gel electrophoresis under non-denaturing conditions (Figure 32).  
 
Figure 32. Cathodic gel electrophoresis under non-denaturing conditions. Lane 1: Upon lyophi-
lization from 40% acetic acid, desBP gives rise to a several multimers that migrate differently on 
the gel. Lane 2: untreated sample of desBP is shown for comparison.  
The tetramer can be easily separated from the oligomeric mixture by size-
exclusion chromatography (SEC) with a Sephadex G-75 column (Figure 33). 
 
Figure 33. Size exclusion chromatogram of desBP after lyophilization from 40% acetic acid. Di-
mer and tetramer species can be easily separated.  
The tetramer should have a quaternary organization similar to that of the 
model represented in Figure 34.  
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Figure 34. Model of the tetramer of RNase A obtained by C-terminal swapping of two N-terminal 
swapped dimers, represented as cartoon.  
CONCLUSIONS AND FUTURE PERSPECTIVES 
As it is well known, under specific conditions bovine pancreatic ribonucle-
ase easily generates two domain-swapped dimers: one dimer (N-dimer) is ob-
tained through swapping of the N-terminal helix (residues 1-15), the second (C-
dimer) is formed through swapping of the C-terminal strand (residues 115-124), 
the latter being promoted by the transition of the cis to trans conformation of 
proline 114. Thus, RNase A can be classified as a bi-functional swapping pro-
tein. In principle, through a sequential alternate swapping of the N- and C-
segment, a linear chain of swapped monomer can be built. However, in the pre-
parative assays that promote both N- and C-swapping many different species are 
observed, such as the two dimers (N- and C-swapped), several trimers and many 
other higher-order oligomers. This variety of different oligomers makes the iso-
lation of a single species not an easy task, and, therefore, the chemical and bio-
logical properties of these oligomers difficult to study. From this point of view, 
desBP is particularly interesting. As shown in the present study, the deletion of 
the residues from 16 to 20 does indeed force the monomer to dimerize via the 
exchange of the N-terminal helix (residues 1-14) between the two subunits, 
leading to a high stability of the dimer. This property suggests that the dimer 
represents an intriguing molecule that can act as a building-block to perform ol-
igomerization experiments. Indeed, the dimer can still be considered a bi-
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functional swapping unit, having the possibility to exchange two C-terminal 
strands each belonging to the two subunits composing the dimer. The C-
terminal swapping of desBP may thus yield only one tetramer (dimer of dimer) 
and/or a more limited number of higher-order oligomers, thus making the isola-
tion of a single species simpler to achieve. Moreover, the oligomerization exper-
iments may be conducted in the best conditions that promote the C-terminal 
swapping. Preliminary, positive results have already been obtained and the work 
along this line is in progress. 
MATERIALS AND METHODS 
Protein production and purification 
The deletion mutant des(16-20)-RNase A (desBP) has been kindly provided 
by the group of Prof. Picone, Department of Chemical Sciences, University of 
Naples “Federico II”, and prepared as described in (Picone, et al., 2005). 
Oligomers have been obtained by lyophilization upon 40% acetic acid incu-
bation of the dimeric derivative. Purification and analyses of desBP oligomers 
have been performed through size-exclusion chromatography using a Superdex 
75 HR 10/30 column, flow rate 0.5 mL/min, attached to an AKTA FPLC system 
(GE-Healthcare), at room temperature. The column has been equilibrated with 
10 mM sodium phosphate pH 7.1, 0.1 M NaCl buffer. Elution was performed 
with the same buffer. The purified oligomers have been kept at 4°C until use.  
Cathodic gel electrophoresis 
Cathodic gel electrophoresis under non-denaturing conditions has been per-
formed according to the procedure described by Goldenberg (Goldenberg, 1989) 
with slight modifications, using a β-alanine/acetic acid buffer, pH 4.0. Gels 
(10% polyacrylamide) have been run at 20 mA for 4 hours at 4 VC. Fixing and 
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staining were performed with 12.5% trichloroacetic acid and 0.1% Coomassie 
brilliant blue (Gotte, et al., 1999). 
Circular Dichroism 
Circular dichroism (CD) spectra were recorded at 20°C using a Jasco J-710 
spectropolarimeter equipped with a Peltier thermostatic cell holder (Model 
PTC-348WI). CD measurements were carried out in the 190-250 nm range us-
ing a 0.1 cm path length cell and 0.2 mg/mL solutions of the protein, in 10 mM 
sodium phosphate pH 7.1, 100 mM NaCl. Before measurements, the instrument 
was calibrated with an aqueous solution of D(+)-10-camphorsulfonic acid at 
290 nm and the samples were pre-equilibrated at 20°C for 5 minutes.  
Thermal unfolding curves were recorded in the 20–80°C range, in 0.5°C 
steps at heating rate 30°C/hour. Transition temperatures were calculated from 
the second derivative of the ellipticity change vs temperature.  
Crystallization and data collection 
A purified solution of desBP at a concentration of 20 mg/mL in 25 mM so-
dium phosphate pH 6.7 has been used to search for the crystallization condi-
tions. Crystals of have been grown from a 1:1 (v/v) mixture of a desBP protein 
solution and a reservoir solution (0.1 M sodium citrate pH 5.6, 16% (w/v) poly-
ethylene glycol 4000, 8-12% (v/v) isopropanol) using the hanging-drop vapor 
diffusion method at 4°C. Drops consisting of 0.5 µL protein mixed with an 
equal volume of precipitating solution have been equilibrated against 500 µL of 
reservoir solution. Prior to the collection of the X-ray data, the crystals have 
been soaked in a reservoir solution containing 20-25% (w/v) glycerol as a cryo-
protectant and flash-frozen in a stream of liquid nitrogen.  
X-ray diffraction data have been collected at 100 K at the ELETTRA Syn-
chrotron (Trieste, Italy) using a 165 mm CCD detector from MAR-Research. 
Diffraction data have been processed using the program suite HKL2000 
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(Otwinowski, et al., 1997). A summary of the indicators commonly used to es-
timate the quality of datasets is given in Table 9.  
The structure of desBP has been solved by molecular replacement using the 
structure of wild-type RNase A (PDB entry 2e3w) as a search model. Refine-
ment of the structure is still in progress. Figures have been drawn using Pymol 
(Schrodinger, 2010). 
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Abstract:	  Glutathione	  synthetases	  catalyze	  the	  ATP-­‐dependent	  synthesis	  of	  glutathione	  from	  L-­‐γ-­‐glutamyl-­‐L-­‐cysteine	  and	  glycine.	  Although	  these	  enzymes	  have	  been	  sequenced	  and	   characterized	   from	   a	   variety	   of	   biological	   sources,	   their	   exact	   catalytic	  mechanism	  is	  not	  fully	  understood	  and	  nothing	  is	  known	  about	  their	  adaptation	  at	  extremophilic	   environments.	   Glutathione	   synthetase	   from	   the	   Antarctic	  eubacterium	   Pseudoalteromonas	   haloplanktis	   (PhGshB)	   has	   been	   expressed,	  purified	   and	   successfully	   crystallized.	   An	   overall	   improvement	   of	   the	   crystal	  quality	   has	   been	   obtained	   by	   adapting	   the	   crystal	   growth	   conditions	   found	  with	  vapor	   diffusion	   experiments	   to	   the	   without-­‐oil	   microbatch	   method.	   The	   best	  crystals	  of	  PhGshB	  diffract	  to	  2.34	  Å	  resolution	  and	  belong	  to	  space	  group	  P212121,	  with	  unit-­‐cell	  parameters	  a	  =	  83.28	  Å,	  b	  =	  119.88	  Å,	  c	  =	  159.82	  Å.	  Refinement	  of	  the	  model,	  obtained	  using	  phases	  derived	  from	  the	  structure	  of	  the	  same	  enzyme	  from	  
Escherichia	   coli	   by	   molecular	   replacement,	   is	   in	   progress.	   The	   structural	  determination	  will	  provide	   the	   first	   structural	   characterization	  of	  a	  psychrophilic	  glutathione	  synthetase	  reported	  to	  date.	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Abstract:	  
γ-­‐glutamyltranspeptidases	   (γ-­‐GTs)	   are	   ubiquitous	   enzymes	   that	   catalyze	   the	  hydrolysis	  of	  γ-­‐glutamyl	  bonds	  in	  glutathione	  and	  glutamine	  and	  the	  transfer	  of	  the	  released	   γ-­‐glutamyl	   group	   to	   amino	   acids	   or	   short	   peptides.	   These	   enzymes	   are	  generally	   synthesized	   as	   precursor	   proteins,	   which	   undergo	   an	   intra-­‐molecular	  autocatalytic	   cleavage	  yielding	  a	   large	  and	  a	   small	   subunit.	   In	   this	   study,	   circular	  dichroism	  and	  intrinsic	  fluorescence	  measurements	  have	  been	  used	  to	  investigate	  the	   structural	   features	   and	   the	   temperature-­‐	   and	   guanidinium	   hydrochloride	  (GdnHCl)-­‐induced	   unfolding	   of	   the	   mature	   form	   of	   the	   γ-­‐GT	   from	   Geobacillus	  
thermodenitrificans	   (GthGT)	   and	   that	   of	   its	   T353A	   mutant,	   which	   represents	   a	  mimic	  of	   the	  precursor	  protein.	  Data	   indicate	   that	   a)	   the	  mutant	   and	   the	  mature	  GthGT	   have	   a	   different	   secondary	   structure	   content	   and	   a	   slightly	   different	  exposure	   of	   hydrophobic	   regions,	   b)	   the	   thermal	   unfolding	   processes	   of	   both	  GthGT	   forms	   occur	   through	   a	   three-­‐state	   model,	   characterized	   by	   a	   stable	  intermediate	   species,	   whereas	   chemical	   denaturations	   proceed	   through	   a	   single	  transition,	   c)	  both	  GthGT	   forms	  exhibit	   remarkable	   stability	  against	   temperature,	  but	   they	   do	   not	   display	   a	   strong	   resistance	   to	   the	   denaturing	   action	   of	   GdnHCl.	  These	  findings	  suggest	  that	  electrostatic	  interactions	  significantly	  contribute	  to	  the	  protein	  stability	  and	  that	  both	  the	  precursor	  and	  the	  mature	  form	  of	  GthGT	  assume	  compact	  and	  stable	  conformations	  to	  resist	  to	  the	  extreme	  temperatures	  where	  G.	  
thermodenidrificans	   lives.	   Owing	   to	   its	   thermostability	   and	   unique	   catalytic	  properties,	   GthGT	   is	   an	   excellent	   candidate	   to	   be	   used	   as	   a	   glutaminase	   in	   food	  industry.	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Abstract:	  Despite	  their	  high	  physiological	  relevance,	  haemoglobin	  crystal	  structures	  with	  NO	  bound	   to	   haem	   constitute	   less	   than	   1%	   of	   the	   total	   ligated	   haemoglobins	   (Hbs)	  deposited	   in	   the	   Protein	   Data	   Bank.	   The	  major	   difficulty	   in	   obtaining	   NO-­‐ligated	  Hbs	  is	  most	  likely	  to	  be	  related	  to	  the	  oxidative	  denitrosylation	  caused	  by	  the	  high	  reactivity	   of	   the	   nitrosylated	   species	  with	  O2.	  Here,	   using	  Raman-­‐	   assisted	   X-­‐ray	  crystallography,	  it	  is	  shown	  that	  under	  X-­‐ray	  exposure	  (at	  four	  different	  radiation	  doses)	  crystals	  of	  nitrosylated	  haemoglobin	  from	  Trematomus	  bernacchii	  undergo	  a	  transition,	  mainly	  in	  the	  β-­‐chains,	  that	  generates	  a	  pentacoordinate	  species	  owing	  to	  photodissociation	  of	  the	  Fe-­‐NO	  bond.	  These	  data	  provide	  a	  physical	  explanation	  for	  the	  low	  number	  of	  nitrosylated	  Hb	  structures	  available	  in	  the	  literature.	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Abstract:	  The	  deletion	  of	  five	  residues	  in	  the	  loop	  connecting	  the	  N-­‐terminal	  helix	  to	  the	  core	  of	   monomeric	   human	   pancreatic	   ribonuclease	   leads	   to	   the	   formation	   of	   an	  enzymatically	   active	   domain-­‐swapped	   dimer	   (desHP).	   The	   crystal	   structure	   of	  desHP	   reveals	   the	   generation	   of	   an	   intriguing	   fibril-­‐like	   aggregate	   of	   desHP	  molecules	   that	   extends	   along	   the	   c	   crystallographic	   axis.	   Dimers	   are	   formed	   by	  three-­‐dimensional	  domain	  swapping.	  Tetramers	  are	  formed	  by	  the	  aggregation	  of	  swapped	   dimers	   with	   slightly	   different	   quaternary	   structures.	   The	   tetramers	  interact	   in	   such	   a	   way	   as	   to	   form	   an	   infinite	   rod-­‐like	   structure	   that	   propagates	  throughout	   the	   crystal.	   The	   observed	   supramolecular	   assembly	   captured	   in	   the	  crystal	  predicts	  that	  desHP	  fibrils	  could	  form	  in	  solution;	  this	  has	  been	  confirmed	  by	   atomic	   force	   microscopy.	   These	   results	   provide	   new	   evidence	   that	   three-­‐dimensional	  domain	  swapping	  can	  be	  a	  mechanism	  for	  the	  formation	  of	  elaborate	  large	  assemblies	  in	  which	  the	  protein,	  apart	  from	  the	  swapping,	  retains	  its	  original	  fold.	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Abstract:	  The	   transpeptidation	   activity	   of	   γ-­‐glutamyltranspeptidase	   from	   Geobacillus	  
thermodenitrificans	   (GthGT)	   is	   negligible	   and	   the	   enzyme	   is	   highly	   thermostable.	  Here	   we	   have	   examined	   the	   effect	   of	   concentrated	   NaCl	   solutions	   on	   structure,	  stability,	   dynamics	   and	   enzymatic	   activity	   of	   GthGT.	   The	   protein	   exhibited	  hydrolytic	  activity	  over	  a	  broad	  range	  of	  NaCl	  concentrations.	  Even	  at	  4.0	  M	  NaCl,	  GthGT	   retained	   more	   than	   90%	   of	   the	   initial	   activity	   and	   showed	   unaltered	  fluorescence	   emission,	   secondary	   structure	   and	   acrylamide	   quenching	   on	  tryptophan	   fluorescence.	  Furthermore,	  at	  2.8	  M	  and	  4.0	  M	  NaCl	   the	   temperature-­‐induced	  unfolding	   profiles	   are	   dramatically	   changed	  with	   large	   (>	   20°C)	   positive	  shifts	  in	  the	  denaturation	  temperature.	  These	  features	  make	  GthGT	  an	  ideal	  system	  to	   be	   used	   in	   industrial	   processes	   that	   require	   high	   temperatures	   and	   high-­‐salt	  environments.	   A	   general	   explanation	   of	   the	   NaCl	   effect	   by	  means	   of	   a	   statistical	  thermodynamic	   model	   is	   also	   provided,	   together	   with	   an	   analysis	   of	   residue	  distribution	  between	  protein	  surface	  and	  interior	  in	  15	  non-­‐redundant	  families	  of	  halophilic	  and	  non-­‐halophilic	  proteins.	  The	  results	  are	   in	   line	  with	  a	  comparative	  sequence	   and	   structural	   analysis	   between	   halophilic	   and	   non-­‐halophilic	   γ-­‐glutamyltranspeptidases	  which	  revealed	  that	  a	  major	  role	  in	  halotolerance	  should	  be	  played	  by	  solvent	  exposed	  negatively	  charged	  residues.	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Abstract:	  Thrombin	  plays	  a	  pivotal	  role	  in	  the	  coagulation	  cascade;	  therefore,	  it	  represents	  a	  primary	   target	   in	   the	   treatment	   of	   several	   blood	   diseases.	   The	   15-­‐mer	   DNA	  oligonucleotide	   5’-­‐GGTTGGTGTGGTTGG-­‐3’,	   known	   as	   thrombin	   binding	   aptamer	  (TBA),	  is	  a	  highly	  potent	  inhibitor	  of	  the	  enzyme.	  TBA	  folds	  as	  an	  antiparallel	  chair-­‐like	   G-­‐quadruplex	   structure,	  with	   two	   G-­‐tetrads	   surrounded	   by	   two	   TT	   loops	   on	  one	   side	   and	   a	   TGT	   loop	   on	   the	   opposite	   side.	   Previous	   crystallographic	   studies	  have	  shown	  that	  TBA	  binds	  thrombin	  exosite	  I	  by	  its	  TT	  loops,	  T3T4	  and	  T12T13.	  In	  order	   to	  get	   a	  better	  understanding	  of	   the	   thrombin-­‐TBA	   interaction,	  we	  have	  undertaken	   a	   crystallographic	   characterization	   of	   the	   complexes	   between	  thrombin	  and	  two	  TBA	  mutants,	  TBA∆T3	  and	  TBA∆T12,	  which	  lack	  the	  nucleobase	  of	  T3	  and	  T12,	  respectively.	  The	  structural	  details	  of	  the	  two	  complexes	  show	  that	  exosite	   I	   is	   actually	   split	   into	   two	   regions,	   which	   contribute	   differently	   to	   TBA	  recognition.	   These	   results	   provide	   the	   basis	   for	   a	   more	   rational	   design	   of	   new	  aptamers	  with	  improved	  therapeutic	  action.	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Abstract:	  Potent	   second-­‐generation	   thrombin	   aptamers	   adopt	   a	   duplex-­‐quadruplex	  bimodular	   folding	   and	   recognize	   thrombin	   exosite	   II	   with	   very	   high	   affinity	   and	  specificity.	  A	  sound	  model	  of	  these	  oligonucleotides,	  either	  free	  or	  in	  complex	  with	  thrombin,	   is	   not	   yet	   available.	  Here,	   a	   structural	   study	   of	   one	   of	   these	   aptamers,	  HD22-­‐27mer,	   is	  presented.	  The	  crystal	  structure	  of	   this	  aptamer	   in	  complex	  with	  thrombin	  displays	  a	  novel	  architecture	  in	  which	  the	  helical	  stem	  is	  enchained	  to	  a	  
pseudo-­‐G-­‐quadruplex.	  The	  results	  also	  underline	  the	  role	  of	   the	  residues	  that	   join	  the	   duplex	   and	   quadruplex	   motifs	   and	   control	   their	   recruitment	   in	   thrombin	  binding.	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Abstract:	  Bovine	   seminal	   ribonuclease	   (BS-­‐RNase)	   acquires	   an	   interesting	   anti-­‐tumor	  activity	   associated	   with	   the	   swapping	   on	   the	   N-­‐terminal.	   The	   first	   direct	  experimental	  evidence	  on	  the	  formation	  of	  a	  C-­‐terminal	  swapped	  dimer	  (C-­‐dimer)	  obtained	   from	  the	  monomeric	  derivative	  of	  BS-­‐RNase,	  although	  under	  non-­‐native	  conditions,	   is	   here	   reported.	   The	  X-­‐ray	  model	   of	   this	   dimer	   reveals	   a	   quaternary	  structure	   different	   from	   that	   of	   the	   C-­‐dimer	   of	   RNase	   A,	   due	   to	   the	   presence	   of	  three	  mutations	   in	   the	  hinge	  peptide	  111–116.	  The	  mutations	   increase	   the	  hinge	  peptide	   flexibility	   and	   decrease	   the	   stability	   of	   the	   C-­‐dimer	   against	   dissociation.	  The	  biological	  implications	  of	  the	  structural	  data	  are	  also	  discussed.	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Abstract:	  Bacteria	   react	   to	   adverse	   environmental	   stimuli	   by	   clustering	   into	   organized	  communities	  called	  biofilms.	  A	  remarkably	  sophisticated	  control	  system	  based	  on	  the	   dinucleotide	   3’?5’	   cyclic	   diguanylic	   acid	   (c-­‐di-­‐GMP)	   is	   involved	   in	   deciding	  whether	   to	   form	   or	   abandon	   biofilms.	   The	   ability	   of	   c-­‐di-­‐GMP	   to	   form	   self-­‐intercalated	  dimers	  is	  also	  thought	  to	  play	  a	  role	  in	  this	  complex	  regulation.	  A	  great	  advantage	   in	   the	   quest	   of	   elucidating	   the	   catalytic	   properties	   of	   the	   enzymes	  involved	   in	   c-­‐di-­‐GMP	   turnover	   (diguanylate	   cyclases	   and	   phosphodiesterases)	  would	   come	   from	   the	   availability	   of	   an	   experimental	   approach	   for	   in	   vitro	  quantification	   of	   c-­‐di-­‐GMP	   in	   real-­‐time.	   Here,	   we	   show	   that	   c-­‐di-­‐GMP	   can	   be	  detected	   and	   quantified	   by	   circular	   dichroism	   (CD)	   spectroscopy	   in	   the	   low	  micromolar	  range.	  The	  method	  is	  based	  on	  the	  selective	  ability	  of	  manganese	  ions	  to	   induce	   formation	   of	   the	   intercalated	   dimer	   of	   the	   c-­‐di-­‐GMP	   dinucleotide	   in	  solution,	  which	  displays	  an	   intense	  sigmoidal	  CD	  spectrum	  in	  the	  near-­‐ultraviolet	  region.	  This	  characteristic	  spectrum	  originates	  from	  the	  stacking	  interaction	  of	  the	  four	  mutually	  intercalated	  guanines,	  as	  it	  is	  absent	  in	  the	  other	  cyclic	  dinucleotide	  3’?5’	   cyclic	   adenilic	   acid	   (c-­‐di-­‐AMP).	   Thus,	   near-­‐ultraviolet	   CD	   can	   be	   used	   to	  effectively	   quantify	   in	   real-­‐time	   the	   activity	   of	   diguanylate	   cyclases	   and	  phosphodiesterases	  in	  solution.	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   the	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   Structure	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   Bound	   to	  Exosite	  II	  Pica,	  A,	  Russo	  Krauss,	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   Crystal	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